Upload
aamer
View
223
Download
9
Embed Size (px)
Citation preview
Umbilical cord antiseptics for preventing sepsis and death
among newborns (Review)
Imdad A, Bautista RMM, Senen KAA, Uy MEV, Mantaring III JB, Bhutta ZA
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library2013, Issue 5
http://www.thecochranelibrary.com
Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
16DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
19AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
25CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
62DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
68FEEDBACK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
68WHAT’S NEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
68CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
68DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
69SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
69DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
69INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iUmbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Umbilical cord antiseptics for preventing sepsis and deathamong newborns
Aamer Imdad1, Resti Ma M Bautista2 , Kathlynne Anne A Senen2, Ma Esterlita V Uy3, Jacinto Blas Mantaring III2, Zulfiqar A Bhutta4
1Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA. 2Section of Newborn Medicine, Department
of Pediatrics, University of the Philippines, Manila, Philippines. 3National Institutes of Health, Manila, University of the Philippines,
Manila, Philippines. 4Division of Women and Child Health, Aga Khan University Hospital, Karachi, Pakistan
Contact address: Zulfiqar A Bhutta, Division of Women and Child Health, Aga Khan University Hospital, Stadium Road, PO Box
3500, Karachi, 74800, Pakistan. [email protected].
Editorial group: Cochrane Pregnancy and Childbirth Group.
Publication status and date: Edited (no change to conclusions), comment added to review, published in Issue 11, 2013.
Review content assessed as up-to-date: 25 March 2013.
Citation: Imdad A, Bautista RMM, Senen KAA, Uy MEV, Mantaring III JB, Bhutta ZA. Umbilical cord antiseptics for pre-
venting sepsis and death among newborns. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD008635. DOI:
10.1002/14651858.CD008635.pub2.
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
The umbilical cord is a structure made of blood vessels and connective tissue that connects the baby and placenta in utero. The umbilical
cord is cut after birth, which separates the mother and her baby both physically and symbolically. Omphalitis is defined as infection of
the umbilical cord stump. Tracking of bacteria along the umbilical vessels may lead to septicaemia that can result in neonatal morbidity
and mortality, especially in developing countries.
Objectives
To determine the effect of application of antimicrobials on newborn’s umbilical cord versus routine care for prevention of morbidity
and mortality in hospital and community settings.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (1 October 2012). In addition, we also searched LILACS
(1982 to 11 October 2012) and HERDIN NeON (October 2012)
Selection criteria
We included randomized, cluster-randomized and quasi-randomized controlled trials of topical cord care compared with no topical
care, and comparisons between different forms of care.
Data collection and analysis
Two review authors independently assessed trials for inclusion, trial quality and subsequently extracted data. Data were checked for
accuracy.
1Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
The search identified 77 trials. We included 34 trials in the review involving 69,338 babies, five studies are awaiting classification and
there are two ongoing community trials. Included studies were conducted in both developed and developing countries. Among the
34 included trials, three were large, cluster-randomized trials conducted in community settings in developing countries and 31 studies
were conducted in hospital settings mostly in developed countries. Data for community and hospital studies were analyzed separately.
The three trials conducted in community settings contributed 78% of the total number of children included in this review. Of the trials
conducted in hospital settings, the majority had small sample sizes. There were 22 different interventions studied across the included
trials and the most commonly studied antiseptics were 70% alcohol, triple dye and chlorhexidine.
Only one antiseptic, chlorhexidine was studied in community settings for umbilical cord care. Three community trials reported data
on all-cause mortality that comprised 1325 deaths in 54,624 participants and combined results showed a reduction of 23% (average
risk ratio (RR) 0.77, 95% confidence interval (CI) 0.63 to 0.94, random-effects, T² = 0.02, I² = 50%) in the chlorhexidine group
compared with control. The reduction in omphalitis ranged from 27% to 56% depending on the severity of infection. Cord separation
time was increased by 1.7 days in the chlorhexidine group compared with dry cord care (mean difference (MD) 1.75 days, 95% CI
0.44 to 3.05, random-effects, T² = 0.88, I² = 100%). Washing of umbilical cord with soap and water was not advantageous compared
with dry cord care in community settings.
Among studies conducted in hospital settings, no study reported data for mortality or tetanus. No antiseptic was advantageous to
reduce the incidence of omphalitis compared with dry cord care in hospital settings. Topical triple dye application reduced bacterial
colonization with Staphylococcus aureus compared with dry cord care (average RR 0.15, 95% CI 0.10 to 0.22, four studies, n = 1319,
random-effects, T² = 0.04, I² = 24%) or alcohol application (average RR 0.45, 95% CI 0.25 to 0.80, two studies, n = 487, random-
effects, T² = 0.00, I² = 0%). There was no advantage of application of alcohol and triple dye for reduction of colonization with
streptococcus. Topical alcohol application was advantageous in reduction of colonization with Enterococcus coli compared with dry cord
care (average RR 0.73, 95% CI 0.58 to 0.92, two studies, n = 432, random-effects, T² = 0.00, I² = 0%) and in a separate analysis, triple
dye increased the risk of colonization compared with alcohol (RR 3.44, 95% CI 2.10 to 5.64, one study, n = 373). Cord separation
time was significantly increased with topical application of alcohol (MD 1.76 days, 95% CI 0.03 to 3.48, nine studies, n = 2921,
random-effects, T² = 6.54, I² = 97%) and triple dye (MD 4.10 days, 95% CI 3.07 to 5.13, one study, n = 372) compared with dry
cord care in hospital settings. The number of studies was insufficient to make any inference about the efficacy of other antiseptics.
Authors’ conclusions
There is significant evidence to suggest that topical application of chlorhexidine to umbilical cord reduces neonatal mortality and
omphalitis in community and primary care settings in developing countries. It may increase cord separation time however, there is no
evidence that it increases risk of subsequent morbidity or infection.
There is insufficient evidence to support the application of an antiseptic to umbilical cord in hospital settings compared with dry cord
care in developed countries.
P L A I N L A N G U A G E S U M M A R Y
Umbilical cord antiseptics for preventing sepsis and death among newborns
The umbilical cord connects the baby and mother during pregnancy. The cord is cut after birth. The cord stump then dries and falls
off, generally within five to 15 days. Infection of the umbilical cord stump (omphalitis), caused by skin bacteria, is a significant cause of
illness and death in newborn babies in developing countries. This review evaluated all studies that assessed antiseptics applied topically
to the umbilical cord to determine if they reduce the risk of cord infection and death. Thirty-four randomised controlled studies
were included involving 69,338 babies. There were 22 different interventions studied. The most commonly studied antiseptics in the
included studies were 70% alcohol, triple dye and chlorhexidine. Three studies were conducted in community settings in developing
countries; the remainder were conducted in hospital settings, mostly in developed countries. Studies conducted in community settings
were large and contributed about 78% of all the participants included in this review. Hospital-based studies were small and had
limitations.
Studies conducted in community settings evaluated the effectiveness of topical application of chlorhexidine and combined results
showed that chlorhexidine reduced risk of death by 23% and the risk of cord infection ranging from 27% to 56%, depending on the
2Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
severity of infection. Topical application of chlorhexidine may increase cord separation time by about 1.7 days, however, this does not
increase subsequent risk of cord infection or death.
None of the studies conducted in hospital settings reported data for risk of death or tetanus. No antiseptic was found to be advantageous
for the prevention of cord infection compared with dry cord care in hospital settings. Topical triple dye application reduced bacterial
colonization with Staphylococcus aureus compared to both dry cord care and alcohol application. There was no advantage of application
of alcohol and triple dye for reduction of colonization with streptococcus. Topical alcohol application was advantageous in the reduction
of colonization with Enterococcus coli compared with dry cord care and triple dye application. Cord separation time was increased
with topical application of alcohol and triple dye compared with dry cord care in hospital settings. There were insufficient studies to
determine the efficacy of other antiseptics.
B A C K G R O U N D
Description of the condition
The umbilical cord is a structure made of blood vessels and con-
nective tissue that connects the baby and placenta in utero. Its
outer surface is a membrane that is bathed in amniotic fluid. The
umbilical cord is cut after birth, which separates the mother and
her baby, both physically and symbolically. The cord stump then
dries, falls off and the wound heals. The natural process of the
umbilical cord falling off involves the formation of an area of sep-
aration between the drying cord and the abdominal wall in which
polymorphonuclear leucocytes (a type of white blood cells) are
present (Oudesluys-Murphy 1990). During this process, material
may collect at this junction that sometimes looks like pus and is
often wrongly identified as an infection. The cord usually separates
between five and 15 days after birth (Oudesluys-Murphy 1987).
Before the separation, the remaining stump can be considered to
be a healing wound and thus a possible route for infection through
the vessels into the baby’s blood stream.
Infection of an umbilical cord may be clinically obvious, but is
also sometimes not apparent. In case of frank infections the cord
may be swollen, the surrounding skin inflamed, or the cord may
be ’smelly’ if infected with anaerobic bacteria (Mullany 2006a).
Tracking of bacteria along the umbilical vessels is not obvious to
the eye, but can cause septicaemia, or result in other focal infections
as a result of blood-borne spread such as septic arthritis (Forshall
1957). In such cases, affected babies may also present with fever,
lethargy or poor feeding, collectively called sepsis, in the neonatal
period.
Description of the intervention
As described above, the umbilical cord stump can be the potential
source of entry of pathogenic microorganisms causing morbidity
and mortality. There are two important considerations in this re-
gard; first, is the colonization of newborn skin and umbilical cord
stump with potential pathogenic microorganisms and second is
the application of harmful substances to the umbilical cord. It is
well known that the skin of the newborn, including the umbilical
stump, is colonized by microorganisms soon after birth (Mir 2011;
Mullany 2012). These microorganisms include both pathogenic
and non-pathogenic species. The profile of organisms colonizing
the cord stump varies according to hygenic conditions at the time
of birth and immediate postpartum period. In high-resource set-
tings, the likely organisms are gram positive ones while in low re-
source, community settings, gram negative organisms seem more
prevalent. A study from US showed that 210 of 211 (99.7%) in-
fants studied were found positive for Staphylococcus aureus at least
once in the first six days of life (Fairchild 1958). A recent study
from community settings from Bangladesh showed that predom-
inant flora that colonize the newborn umbilical stump were gram
negative (Escherichia coli, Klebsiella pneumoniae, and Pseudomonasspp) (Mullany 2012). Pathogenic bacteria such as Escherichia coli,Klebsiella pneumoniae, and Pseudomonas spp and streptococci can
track up the umbilical stump causing infection. It is therefore es-
sential to keep the cord clean.
The practice of cord cutting at birth and care of the umbilical
stump afterwards varies according to local practice and culture
(Elhassani 1984; Mullany 2006; Mullany 2007). In many parts
of the world, deliveries occur at home and the cord is cut with
unsterile tools such as used razors or scissors after which various
substances are applied including mustard oil, turmeric, charcoal,
grease, cow dung or dried banana to speed up cord separation (Mir
2011; Mullany 2007; Mullany 2009; Smith 2009). This combi-
nation of unhygienic cutting of cord and application of poten-
tial harmful substances is an important sources of bacterial infec-
tion and neonatal tetanus (Bennett 1997; Mullany 2007; Mullany
2009). Up to this point, there is a general agreement about the
’clean’ technique for cutting the cord using a sterile cutting in-
strument (blade or scissors) and clean hands to avoid infection
3Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Blencowe 2011), however, there is less agreement on what is the
best care of the cord stump (Blencowe 2011; Zupan 2004).
The most frequent modern practice of umbilical cord care is ap-
plying antimicrobials to the cord stump. These include antisep-
tics (such as alcohol, silver sulphadiazine, iodine, chlorhexidine
(CHX); and dyes such as triple dye, gentian violet, acriflavine and
eosin) and/or topical application of antibiotics (for example, bac-
itracin, neomycin, nitrofurazone, or tetracycline, or moisture ab-
sorbing powders). These substances may be used as solutions in
water, alcohol, detergent or ointments. Another approach is to
keep the cord clean and dry without applying anything and this is
recommended by the World Health Oraganization (WHO 1999).
A previous approach was to bath the baby soon after birth with
an antimicrobial solution such as hexachlorophene, however, hex-
achlorophene is no longer recommended in newborn babies as it is
absorbed through the skin and is neurotoxic (WHO 1999). One
potential side effect of topical antimicrobials is the delay in cord
separation time, which can potentially increase the risk of bacterial
entry (Novack 1988). However, it has been shown that it does not
increase the risk of mortality (Mullany 2006b).
How the intervention might work
Studies from developed countries have shown that use of an anti-
septic on umbilical cord stump in hospital nurseries significantly
reduced umbilical colonization rates (Barrett 1979; Pezzati 2002;
Speck 1977). Seventy per cent alcohol has been used since the
1900s for routine cord care along with antimicrobial solutions such
as triple dye, tincture of iodine, iodophors, antibiotic ointments,
silver sulphadiazine and CHX. Soaking the umbilical stump in
70% alcohol rapidly kills gram positive and gram negative bac-
teria. However, it has been shown in several hospital studies to
be less effective in controlling umbilical colonization than other
antimicrobials such as triple dye or CHX (Panyavudhikrai 2002;
Pezzati 2002). Despite its limitations, its low cost and availabil-
ity have led to widespread use, especially in low-resource settings
(WHO 1999).
Recently, CHX has been studied for cord care in community set-
tings (Arifeen 2012; Mullany 2006). CHX is a broad spectrum
antiseptic that is extensively used in dental, obstetric and surgical
scrub. It has also been used in obstetrics, peripartum, perineal and
vaginal washes in concentrations as high as 4% (McClure 2007).
Safety studies in newborn infants exposed to CHX washes in var-
ious concentrations found no evidence of toxicity even in babies
in which percutaneous absorption may have taken place (Aggett
1981; Johnsson 1987). CHX is currently included in WHO’s Es-
sential Drugs List (WHO 2011).
Why it is important to do this review
According to a recent estimate about 40.3% (3.1 million) of all
deaths in children less than five years occurred in the neonatal
period (Liu 2012). Most of these deaths occurred in developing
countries and infections, along with complications of prematurity
are the most important cause of mortality in the neonatal period
(Liu 2012). In populations with high neonatal mortality rates,
infections account for approximately half of all newborn deaths
(Lawn 2005). Infection of the cord stump, called omphalitis, is a
significant cause of mortality and morbidity in developing coun-
tries (Agrawal 2012; Lehmann 1999; Mir 2011; Mullany 2007;
Mullany 2009; Sawardekar 2004; Thaver 2009). The infection
typically presents as a superficial cellulitis that may progress to
involve the abdominal wall and eventually to necrotizing fasci-
itis, myonecrosis, or systemic disease (Gallagher 2010). The risk
is greatest in situations where deliveries take place at home, often
with unskilled traditional birth attendants who do not employ
clean delivery practices (Darmstadt 2009; Mullany 2009). Om-
phalitis is relatively rare in developed countries with an overall in-
cidence rate which varies from 0.2% to 0.7% (McKenna 1977).
Incidence of omphalitis in developing countries in community
settings may range up to 21% (Mir 2011). In these settings, the
mortality rate among all infants with omphalitis, including those
who develop complications, is estimated at up to 46% (Mullany
2009). The mortality rate is significantly higher (about 71%) af-
ter the development of necrotizing fasciitis or myonecrosis (Sawin
1994). Suggested risk factors for poor prognosis include male sex,
prematurity or being small-for-gestational age, and septic delivery
(Faridi 1993; Gallagher 2010; Mullany 2007).
The WHO and American Academy of Pediatrics recommend good
hygiene at delivery, and promote dry cord care practice after birth
(AAP 2003; WHO 1999). These recommendations however, are
based on insufficient evidence in favour of or against an antiseptic
(McClure 2007; Zupan 2004). The aim of this review is to provide
data useful for identifying good practice in both high- and low-
income countries.
O B J E C T I V E S
To determine the effect of application of antimicrobials on the
umbilical cord of newborns versus routine care for prevention of
morbidity and mortality in hospital and community settings.
M E T H O D S
Criteria for considering studies for this review
Types of studies
4Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Randomized, cluster-randomized and quasi-randomized con-
trolled trials.
Types of participants
Live newborns born to mothers with or without risk factors for the
development of infection (for example, chorioamnionitis, preterm
rupture of membranes, urinary tract infection), regardless of place
of delivery (home, hospital, non-institutional birth, etc) and ges-
tational age and birthweight.
Types of interventions
We evaluated the following interventions.
1. Antiseptic versus no antiseptic or placebo/dry cord care.
2. Antibiotics versus no antibiotic.
3. Antiseptic versus antibiotic.
4. Antiseptic versus antiseptic.
5. Single versus multiple application.
6. Washing umbilical cord with soap/water versus dry cord
care.
Those studies were excluded where a combination of antiseptic
and antibiotic was used. Studies that evaluated hexachlorophene
were excluded as the antiseptic had been removed from the market
because of central nervous toxicity.
Types of outcome measures
Primary outcomes
• All-cause mortality
• Confirmed or suspected sepsis
• Omphalitis
• Tetanus
Confirmed sepsis is defined as clinical signs and symptoms consis-
tent with infection and microbiologically proven with a positive
blood culture, cerebrospinal fluid culture, urine culture or culture
from a normally sterile site (e.g. pleural fluid, peritoneal fluid or
autopsy specimens) for bacteria or fungi.
Suspected sepsis is defined as clinical signs and symptoms consis-
tent with sepsis without isolation of a causative organism.
Tetanus is defined as trismus (spasm of the muscles involved in
opening of the jaws) and severe generalized muscular spasms not
attributable to other causes (i.e. hypocalcaemia, phenothiazine re-
action, strychnine poisoning) (AAP 2003).
Omphalitis is defined as clinical signs and symptoms of umbilical
stump infection which include the following.
Localized infection:
1. purulent or malodorous discharge from the umbilical
stump;
2. periumbilical erythema;
3. oedema;
4. tenderness.
Three case definitions have been described by Mullany 2006a to
describe the severity of omphalitis and had been used wherever
data were available. The three definitions are described below.
Algorithm 1: Moderate or severe redness.
Algorithm 2: Moderate redness with pus, or severe redness (with-
out regard to pus).
Algorithm 3: Severe redness with pus.
Extensive local disease that includes conditions such as necrotizing
fasciitis or myonecrosis, which are typically found in a perium-
bilical location but may spread across the abdominal wall, onto
the flanks and back, and into the scrotum. These signs may also
suggest infection by both aerobic and anaerobic organisms and
include the following:
1. ecchymoses, violaceous discolorations;
2. bullae;
3. peau d’orange appearance (the skin looks like orange peel);
4. crepitus;
5. petechiae;
6. progression of cellulitis despite antimicrobial therapy
(Gallagher 2010).
Secondary outcomes
• Bacterial colonization
• Time to cord separation
Search methods for identification of studies
Electronic searches
We contacted the Trials Search Co-ordinator to search the
Cochrane Pregnancy and Childbirth Group’s Trials Register (1
October 2012).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of EMBASE;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
EMBASE, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
5Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
In addition, we searched LILACS (1982 to 11 October 2012)
using the search strategy detailed in Appendix 1, and HERDIN
NeON, the Philippine database of local science journals (October
2012).
We did not apply any language restrictions.
Data collection and analysis
Selection of studies
Two review authors independently assessed for inclusion potential
studies identified as a result of the search strategy. We resolved any
disagreement through discussion or, if required, we consulted a
third person.
Data extraction and management
For eligible studies, at least two review authors extracted the data.
We resolved discrepancies through discussion or, if required, we
consulted a third person. We entered data into Review Manager
software (RevMan 2011) and checked for accuracy.
When information regarding any of the above was unclear, we
attempted to contact authors of the original reports to provide
further details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook forSystematic Reviews of Interventions (Higgins 2011). We resolved
any disagreement by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to conceal
the allocation sequence and determine whether intervention allo-
cation could have been foreseen in advance of, or during recruit-
ment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomization;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3) Blinding (checking for possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that the
lack of blinding could not have affected the results. We assessed
blinding separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel;
• low, high or unclear risk of bias for outcome assessors.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition
and exclusions from the analysis. We stated whether attrition and
exclusions were reported, the numbers included in the analysis at
each stage (compared with the total randomized participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we included the missing data in the analyses.
We assessed methods as:
• low risk of bias (e.g. less than 10% missing data);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomization);
• unclear risk of bias.
If missing data could not be supplied by the trial authors, we
carried out subgroup analysis for groups with sufficient outcome
data.
(5) Selective reporting (checking for reporting bias)
6Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it was clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review had been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes had been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest were
reported incompletely and so could not be used; study failed to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other sources of bias
We described for each included study any important concerns we
had about other possible sources of bias.
We assessed whether each study was free of other problems that
could put it at risk of bias (e.g. study design, imbalance in baseline
data):
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Cochrane Hand-book (Higgins 2011). With reference to (1) to (6) above, we as-
sessed the likely magnitude and direction of the bias and whether
we considered it likely to impact on the findings. We explored
the impact of the level of bias through sensitivity analyses - seeSensitivity analysis.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals. For the three included cluster-ran-
domized trials, data were entered using the generic inverse vari-
ance option in RevMan 2011 to allow adjustment of the variance
for cluster effect (Higgins 2011).
Continuous data
For continuous data, we used the mean difference with 95% con-
fidence intervals. For studies with multiple groups, comparison
groups were combined into a single pair-wise comparison. Stan-
dard deviations were adjusted using the formula in the CochraneHandbook (Higgins 2011).
Unit of analysis issues
We included cluster-randomized trials in the analyses along with
individual-randomized trials. We used cluster-adjusted values
from the trials, irrespective of the method used. In case a trial was
not adjusted for cluster design, results were adjusting by inflating
the standard error of the effect size by quare root of design effect
given in the study.
Dealing with missing data
For included studies, we took note of levels of attrition. We ex-
plored the impact of including studies with high levels of missing
data in the overall assessment of treatment effect by using sensi-
tivity analysis.
For all outcomes, we carried out analyses, as far as possible, on an
intention-to-treat basis, i.e. we included all participants random-
ized to each group in the analyses, and analyzed all participants in
the group to which they were allocated, regardless of whether or
not they received the allocated intervention.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the T², I² and Chi² statistics. We considered heterogeneity as sub-
stantial if an I² was greater than 50% and either the T² was greater
than zero, or the P value was less than 0.10 in the Chi² test for
heterogeneity.
Assessment of reporting biases
We planned that, if there were 10 or more studies in the meta-
analysis, we would investigate reporting biases (such as publication
bias) using funnel plots. We intended to assess funnel plot asym-
metry visually. If asymmetry was suggested by a visual assessment,
we planned to perform exploratory analyses to investigate it.
Data synthesis
We performed statistical analysis using the Review Manager soft-
ware (RevMan 2011). We used the random-effects analysis to pro-
duce an overall summary of the average treatment effect across
trials considering the different interventions across different eco-
nomic settings. We have presented the results as the average treat-
ment effect with its 95% confidence interval, and the estimates of
T² and I².
Subgroup analysis and investigation of heterogeneity
We planned to the following subgroup analyses:
1. preterm (gestational age less than 37 weeks) versus term
(gestational age 37 weeks or more);
2. hospital setting; community-based studies; settings mixed
or undefined;
7Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3. trials carried out in Europe-Americas; Western Pacific;
Eastern Mediterranean; South-East Asia; Africa.
Gestational age and birthweight are relevant subgroups since the
incidence of sepsis is high among low birthweight and preterm
infants. Causative organisms, corresponding susceptibility to an-
tiseptics and severity of disease, may differ in hospital versus com-
munity settings. We therefore analyzed hospital and community-
based studies separately. Baseline neonatal mortality rate varies
with region: Europe-America (11-12/1000 livebirths); Western
Pacific (19/1000 livebirths); Eastern Mediterranean (40/1000 live-
births); Southeast Asia (38/1000 livebirths); Africa (44/1000 live-
births) (WHO 2006).
We included all primary outcomes in the subgroup analysis (mor-
tality, confirmed or suspected sepsis, tetanus and omphalitis).
Sensitivity analysis
We carried out sensitivity analysis removing studies of low quality.
We also carried out sensitivity analyses to investigate the effect of
missing data:
• less than 5% missing data;
• 5% to 10% missing data;
• 10% to 20% missing data;
• 20% or more missing data.
R E S U L T S
Description of studies
See Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
The search identified 77 trials; we included 34 studies in the review,
involving 69,338 babies (See Characteristics of included studies).
Thirty-six studies were excluded (see Characteristics of excluded
studies). Five studies are awaiting classification (see Characteristics
of studies awaiting classification) while there are two ongoing com-
munity trials (see Ongoing studies).
Included studies
Thirty-four trials reported in 46 papers met the inclusion cri-
teria. More than one report was available for six (17%) trials
(Arifeen 2012; Evens 2004; Mullany 2006; Speck 1977; Soofi
2012; Suliman 2010). When results of an included trial were re-
ported in more than one publication, we extracted data from all
reports but counted it as one trial. All included trials reported data
that could be included in a meta-analysis.
There were three large, cluster-randomized trials conducted in
community settings (Arifeen 2012; Mullany 2006; Soofi 2012).
These three trials contributed 78% of the total number of children
included in this review. The two ongoing studies are also com-
munity trials that assess effect of topical application of chlorhexi-
dine to umbilical cord. One study is being conducted in Zambia
(Hamer 2010) and other in Pemba (Sazawal 2012).
Of the trials conducted in hospital settings, the majority had small
sample sizes. Sample size of these 31 (91%) trials ranged between
71 and 2241.
Seventeen (50%) of the included studies had a ’dry cord care’ group
and 16 (47%) studies comprised more than two study groups.
The studies were conducted in both developing and developed
countries. All three community studies were conducted in devel-
oping countries and most of the hospital-based studies were con-
ducted in developed countries. There were eight studies conducted
in USA (Barrett 1979; Evens 2004; Gladstone 1988; Golombek
2002; Rosenfeld 1989; Schuman 1985; Speck 1977; Suliman
2010), four in Canada (Dore 1998; Janssen 2003; Medves 1997;
Rush 1986), three in Taiwan (Hsu 1999; Hsu 2010; Huang 2001),
two each in Iran (Ahmadpour-Kacho 2006; Nourian 2009), Nor-
way (Meberg 1985; Meberg 1990), Italy (Pezzati 2002; Pezzati
2003), and Pakistan (Shafique 2006; Soofi 2012) and one each in
Saudi Arabia (Al-Binali 2006), Palestine (Arad 1981), Bangladesh
(Arifeen 2012), Scotland (Bain 1994), Peru (Davila 2007), Ger-
many (Kapellen 2009), England (Mugford 1986), Nepal (Mullany
2006), Japan (Oishi 2004), Thailand (Panyavudhikrai 2002), and
Spain (Perapoch 1993).
There were 18 (52%) studies that included full-term babies, five
(15%) included preterm babies (Bain 1994; Gladstone 1988;
Pezzati 2002; Pezzati 2003; Rosenfeld 1989), seven (20%) in-
cluded both term and preterm babies (Ahmadpour-Kacho 2006;
Arifeen 2012; Davila 2007; Janssen 2003; Mullany 2006; Oishi
2004; Soofi 2012) and gestational age was not mentioned in
four (12%) studies (Al-Binali 2006; Barrett 1979; Mugford 1986;
Schuman 1985).
There were 22 different interventions studied across the included
trials. These included topical antiseptics, antibiotics and measures
such as washing the cord with soap and water. There were 20 stud-
ies (58%) that evaluated topical alcohol application, 10 (29%)
triple dye, nine (26%) chlorhexidine, five (14%) Silver Sulfadi-
azine, three (8%) Povidine and two (5%) salicylic powder. There
was one study each for Beniktol, neomycin, bismuth, breastmilk,
bacitracin, benzine, hydrophobic gauze, mercurochrome, green
clay powder, katoxin, fuschine, and citrane.
Of the primary outcomes considered, three trials (Arifeen 2012;
Mullany 2006; Soofi 2012) evaluated the effect of cord care on
mortality. Thirteen studies reported data on omphalitis. One study
reported data on sepsis (Pezzati 2003) and one study reported sep-
sis-related mortality (Mullany 2006). No study reported tetanus.
Of the secondary outcomes, 26 studies reported cord separation
time, 12 reported bacterial colonization.
8Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Excluded studies
Thirty-six studies were excluded (See Characteristics of excluded
studies). Reasons for exclusion were: 1) not a randomized con-
trolled trial, 2) not a cord care study or, 3) effect of individual
intervention was not established due to co-interventions.
Risk of bias in included studies
See Figure 1 for summary of assessment of risk of bias.
9Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 1. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
10Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Allocation
Twelve (35%) studies had adequate methods of sequence genera-
tion, eight (24%) had inadequate methods or were quasi-random-
ized trials while in 14 (41%) studies, methods were inadequately
described to make a complete assessment.
Allocation was adequately concealed in seven (21%) studies while
in 22 (65%) studies it was not mentioned or unclear. Five (15%)
studies had inadequate methods of allocation concealment.
Blinding
Method of blinding was not done, not feasible, or not mentioned
in 30 (88%) studies. Three studies had “adequate” methods of
blinding. The study of Mullany 2006 mentioned that investiga-
tors, field workers and participants were masked to chlorhexidine
and soap and water but not to the dry cord care.
Incomplete outcome data
Seventeen (50%) studies reported data on attrition and exclusion
while 14 studies (41%) did not describe enough details on follow-
up. There was insufficient information in three (9%) studies to
make a complete assessment.
Selective reporting
It is difficult to assess true selective reporting bias when proto-
cols of the included studies are not available. Review authors had
access to the protocols of three studies to make an assessment
(Arifeen 2012; Mullany 2006; Soofi 2012) and they were con-
sidered to be adequate. In the rest of the studies, the judgment
was made based on variables mentioned in the methods section
compared to those reported in the results section of the study.
Based on this assessment, 13 studies had adequate descriptions
of outcomes in the results section for the outcomes mentioned
in the methods section (Ahmadpour-Kacho 2006; Arifeen 2012;
Bain 1994; Barrett 1979; Dore 1998; Hsu 2010; Medves 1997;
Mugford 1986; Mullany 2006; Nourian 2009; Rosenfeld 1989;
Soofi 2012; Suliman 2010).
Other potential sources of bias
In the study of (Ahmadpour-Kacho 2006), baseline characteristics
showed more vaginal deliveries in the dry care, alcohol and silver
groups compared with the breastmilk group. Arad 1981 included
the outcome of sepsis but no bacterial cultures were obtained
to prove the condition. The community trial from Bangladesh
(Arifeen 2012), showed that there was no effect of multiple cleans-
ing with chlorhexidine on neonatal mortality. This may be due to
the fact that the study was not powered enough to detect a sig-
nificant difference in this arm, as pointed out by authors (Arifeen
2012). In the study of Bain 1994, there was a higher rate of rupture
of membranes in the dry care group. In Davila 2007, there was
no table of baseline characteristics. In the study of Evens 2004,
there was a higher rate of vaginal delivery in the alcohol group.
The studies by Golombek 2002 and Shafique 2006 gathered data
on the incidence of omphalitis by telephone calls and no home
visits were made to make an assessment. This could have resulted
in false positives or negatives as symptoms were reported by moth-
ers. Kapellen 2009 had no table of baseline characteristics but the
text mentioned that the groups were comparable in terms of sex,
ethnicity, birthweight, birth length, gestational age, model of de-
livery and Apgar score. No description of baseline characteristics
of study participants was given in five studies (Al-Binali 2006;
Meberg 1985; Meberg 1990; Perapoch 1993; Speck 1977). The
study of Medves 1997 had no table of baseline characteristics.
Mugford 1986 mentioned in the text that the groups were com-
parable in terms of sex, birthweight and mode of delivery. The
study of Oishi 2004 states that the babies in the alcohol group
had low birthweights but the proportion was not mentioned. The
desired sample size in Soofi 2012was not achieved due to a security
situation in the study area.
Effects of interventions
Antiseptics versus dry cord care/placebo
There were 18 studies that had a comparison group between ’dry
cord care’ and ’an antiseptic’. Fifteen of these studies were con-
ducted in hospital settings while three were conducted in commu-
nity settings (Arifeen 2012; Mullany 2006; Soofi 2012).
The antiseptics included in this comparison were: alcohol, triple
dye, chlorhexidine, salicylic sugar powder, green clay powder, silver
sulphadiazine, benzine, katoxin powder, fuschine, zinc powder and
breastmilk.
Community studies
Primary outcomes
Mortality
Only one antiseptic, i.e. chlorhexidine was studied in community
settings for umbilical cord care. Three community trials reported
data on all-cause mortality (Arifeen 2012; Mullany 2006; Soofi
11Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2012). There were 1325 deaths in 54,624 participants of three
studies and combined results showed a reduction of 23% in the
intervention group compared with control (average risk ratio (RR)
0.77, 95% confidence interval (CI) 0.63 to 0.94; random-effects,
T² = 0.02, I² = 50% (Analysis 1.1)).
Sepsis
No community-based study reported data on the incidence of
sepsis, however, one trial (Mullany 2006) from Nepal reported data
on sepsis-specific mortality and showed a 31% reduction in the
chlorhexidine group compared with dry cord care but the results
were not statistically significant (RR 0.69, 95% CI 0.40 to 1.18).
Omphalitis
Antiseptics were associated with a significant reduction in om-
phalitis ranging from 27% to 56% depending on the severity of
infection: redness extending to skin: average RR 0.73, 95% CI
0.64 to 0.83; three studies, random-effects, T² = 0.00, I² = 34%
(Analysis 1.2); redness with pus or severe redness: average RR 0.69,
95% CI 0.60 to 0.79; three studies, random-effects, T² = 0.00,
I² = 0% (Analysis 1.3); severe redness with pus: average RR 0.44,
95% CI 0.28 to 0.69; three studies, random-effects, T² = 0.03,
I² = 19% (Analysis 1.4), with the most significant reduction in
severe cases.
Secondary outcomes
Bacterial colonization
One study (Arifeen 2012) reported data on bacterial colonization
and showed a significant reduction in bacterial colonization of
Staphylococcus aureus (RR 0.27, 95% CI 0.23 to 0.31 (Analysis
1.5)); Enterococcus coli (RR 0.50, 95% CI 0.46 to 0.54 (Analysis
1.6)) and streptococci (RR 0.28, 95% CI 0.22 to 0.37 (Analysis
1.7)) with topical chlorhexidine application compared with con-
trol.
Cord separation time
Data for cord separation time was available from two studies
(Arifeen 2012; Mullany 2006), carried out in Bangladesh and
Nepal respectively. In the study by Mullany 2006, cord separa-
tion time was longer in the chlorhexidine group (5.32 ± 2.4 days)
compared with the dry cord care group (4.24 ± 1.6 days). There
was no increased risk of mortality in children who had increased
cord separation time (Mullany 2006). In Arifeen 2012, separation
time in the combined chlorhexidine group (7.20 ± 3.0 days) was
2.40 (95% CI 2.17 to 2.64) days longer than among babies not
exposed to chlorhexidine (4.79 ± 1.8 days) (Unpublished data).
The combined data for both of these studies showed that cord sep-
aration time was 1.7 days longer in the chlorhexidine group com-
pared with the non-chlorhexidine group (mean difference (MD)
1.75, 95% CI 0.44, to 3.05, random-effects, T² = 0.88, I² = 100%
(Analysis 1.8)).
Hospital studies
Primary outcomes
Mortality/sepsis/tetanus
Among studies conducted in hospital settings, no study reported
data on mortality, sepsis or tetanus for the comparison of antisep-
tics versus dry cord care/placebo.
Omphalitis
Five studies reported data for incidence of omphalitis (Bain 1994;
Janssen 2003; Kapellen 2009; Nourian 2009; Pezzati 2002). There
was no significant difference for the incidence of omphalitis when
alcohol (three studies) (average RR 0.92, 95% CI 0.62 to 1.39),
triple dye (two studies) (average RR 0.71, 95% CI 0.13 to 3.73),
chlorhexidine (one study) (RR 0.28, 95% CI 0.06 to 1.35), sali-
cylic sugar powder (one study) (RR 0.21, 95% CI 0.01 to 4.38)
and green clay powder (one study) (RR 0.48, 95% CI 0.04 to
5.26) were compared with dry cord care/placebo (Analysis 2.1).
Secondary outcomes
Bacterial colonization
Compared with dry cord care/placebo, bacterial colonization of
umbilical cord with Staphylococcus aureus was significantly reduced
with application of triple dye (four studies) (average RR 0.15,
95% CI 0.10 to 0.22, random-effects, T² = 0.04, I² = 24%), silver
sulphadiazine (two studies) (average RR 0.72, 95% CI 0.60 to
0.87, random-effects, T² = 0.00, I² = 0%), chlorhexidine (one
study) (RR 0.65, 95% CI 0.55 to 0.77), salicylic sugar powder (one
study) (RR 0.32, 95% CI 0.17 to 0.58), green clay powder (one
study) (RR 0.51, 95% CI 0.31 to 0.82) and fuschine (one study)
(RR 0.52, 95% CI 0.32 to 0.84). For the same control group, there
was no significant difference for alcohol (two studies) (average RR
0.61, 95% CI 0.11 to 3.36), benzine (one study) (RR 0.99, 95%
12Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
CI 0.90 to 1.09). Compared with dry cord care/placebo, there was
a significantly increased risk of bacterial colonization of umbilical
cord with Staphylococcus aureus associated with use of katoxin (one
study) (RR 1.43, 95% CI 1.02 to 2.00). See Analysis 2.2.
For the outcome of colonization with streptococci, there was a
significant reduction with application of silver sulphadiazine (two
studies) (average RR 0.62, 95% CI 0.43 to 0.89, random-effects,
T² = 0.00, I² = 0%) and fuschine (one study) (RR 0.19, 95%
CI 0.04 to 0.85) compared with dry cord care/placebo. For the
same comparison group, there was no difference in colonization
of streptococci with the application of alcohol (two studies) (RR
0.42, 95% CI 0.15 to 1.19, random-effects, T² = 0.33, I² = 50%),
triple dye (three studies) (average RR 0.57, 95% CI 0.28 to 1.18,
random-effects, T² = 0.31, I² = 79%), chlorhexidine (one study)
(RR 0.53, 95% CI 0.27 to 1.04), salicylic sugar powder (one study)
(RR 0.74, 95% CI 0.29 to 1.90). However, there was an increased
risk of streptococcal bacterial colonization associated with the use
of green clay powder (one study) (RR 4.62, 95% CI 2.41 to 8.84)
and katoxin powder (one study) (RR 5.87, 95% CI 3.12 to 11.05).
See Analysis 2.3.
Compared with dry cord care/placebo, there was a significant re-
duction in the colonization of Enterococcus coli with topical appli-
cation of alcohol (two studies) (average RR 0.73, 95% CI 0.58
to 0.92, random-effects, T² = 0.00, I² = 0%), silver sulphadiazine
(one study) (RR 0.70, 95% CI 0.53 to 0.93) and chlorhexidine
(one study) (RR 0.59, 95% CI 0.39 to 0.90). In contrast, there
was no significant difference with application of triple dye (two
studies) (average RR 0.79, 95% CI 0.53 to 1.17, random-effects,
T² = 0.06, I² = 79%), salicylic sugar powder (one study) (RR 0.59,
95% CI 0.32 to 1.10), green clay powder (one study) (RR 1.27,
95% CI 0.79 to 2.05) and katoxin powder (one study) (RR 1.12,
95% CI 0.70 to 1.81). There was increased risk of Enterococcus colicolonization associated with application of fuschine (one study)
(RR 2.04, 95% CI 1.33 to 3.13). See Analysis 2.4.
Cord separation time
There was a significant increase in cord separation time when
alcohol was applied to umbilical cord compared with dry cord
care/placebo (nine studies) (MD 1.76 days, 95% CI 0.03 to 3.48,
random-effects, T² = 6.54, I² = 97%). There was one study each
for triple dye (MD 4.10 days, 95% CI 3.07 to 5.13), katoxin
powder (MD 0.80 days, 95% CI 0.18 to 1.42), fuschine (MD 2.80
days, 95% CI 2.01 to 3.59) and silver sulphadiazine (MD 3.60
days, 95% CI 2.66 to 4.54) and these antiseptics were associated
with a significant increase in cord separation time compared with
dry cord care/placebo. One study each for zinc powder (MD -
1.82 days, 95% CI -2.23 to -1.41), salicylic sugar powder (MD -
1.90 days, 95% CI -2.47 to -1.33), green clay powder (MD -0.80
days, 95% CI -1.36 to -0.24), breastmilk (MD -1.69 days, 95%
CI -2.31 to -1.07) and chlorhexidine (MD -0.80 days, 95% CI -
1.21 to -0.39) were associated with decreased cord separation time
compared with dry cord care. See Analysis 2.6.
Antibiotics versus no antibiotic
There were no studies in community or hospital settings that in-
vestigated this comparison.
Antiseptics versus antibiotics
Community studies
There was no study that was conducted in community settings for
this comparison.
Hospital studies
Primary outcomes
Mortality/sepsis/tetanus/omphalitis
Among studies conducted in hospital settings, no data were re-
ported on mortality, sepsis, tetanus or omphalitis for this compar-
ison.
Secondary outcomes
Bacterial colonization
One study compared triple dye (RR 0.65, 95% CI 0.03 to 12.87),
silver sulphadiazine (RR 2.18, 95% CI 0.42 to 11.33) and povi-
done (RR 2.18, 95% CI 0.42 to 11.33) with bacitracin and there
were no differences in bacterial colonization rates for Staphylococ-cus aureus (Analysis 3.1). No data were reported for colonization
with streptococcus and enterococcus.
Cord separation time
Cord separation time was significantly reduced when umbilical
cord was treated with triple dye compared with bacitracin (one
study) (MD -5.60 days, 95% CI -9.36 to -1.84) and neomycin
(one study) (MD -4.30, 95% CI -6.27 to -2.33). There was no
difference in cord separation time when silver sulphadiazine was
compared with neomycin (one study) (MD -1.40 days, 95% CI
-3.65 to 0.85). Cord separation time was significantly reduced
when umbilical cord was treated with povidone versus bacitracin
13Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(one study) (MD -2.00 days, 95% CI -3.67 to -0.33). Similarly,
alcohol was associated with a significantly reduced cord separation
time compared with beniktol (MD -2.33 days, 95% CI -3.77 to
-0.89). See Analysis 3.2.
Antiseptics versus antiseptics
Community studies
There was no study that was conducted in community settings for
this comparison.
Hospital studies
Primary outcomes
Sepsis and mortality
Among studies conducted in hospital settings, no study reported
data on mortality or tetanus. One study compared chlorhexidine
with salicylic acid powder and reported no difference in the inci-
dence of sepsis between the two groups (RR 1.11, 95% CI 0.07
to 17.50 (Analysis 4.1)).
Omphalitis
Three studies evaluated triple dye versus alcohol and reported no
significant reduction in the incidence of omphalitis in the triple dye
group compared with the alcohol-treated group (average RR 0.48,
95% CI 0.14 to 1.63, random-effects, T² = 0.54, I² = 41%). There
was no difference when triple dye was compared with salicylic
sugar powder (one study) (RR 4.29, 95% CI 0.21 to 88.65) and
katoxin (one study) (RR 2.13, 95% CI 0.19 to 23.34).
Similarly, there was no difference in the incidence of omphalitis
for the comparisons of alcohol versus povidone (RR 0.84, 95%
CI 0.62 to 1.16, one study), alcohol versus salicylic powder (RR
4.69, 95% CI 0.23 to 97.03, one study), alcohol versus green clay
powder (RR 2.07, 95% CI 0.19 to 22.60, one study), alcohol ver-
sus katoxin (RR 2.10, 95% CI 0.19 to 22.97, one study), alcohol
versus fuschine (RR 2.10, 95% CI 0.19 to 22.97, one study) and
alcohol versus chlorhexidine (RR 2.77, 95% CI 0.12 to 66.49, one
study). One study also compared chlorhexidine with hydrophobic
gauze and reported no significant difference in the incidence of
omphalitis (RR 1.36, 95% CI 0.55 to 3.36).
In contrast, triple dye was associated with a significant reduction
in the incidence of omphalitis compared with povidone-iodine
(RR 0.15, 95% CI 0.07 to 0.32, one study). See Analysis 4.2.
Secondary outcomes
Bacterial colonization
Bacterial colonization with Staphylococcus aureus was significantly
reduced when umbilical cord was treated with triple dye compared
with alcohol (two studies) (average RR 0.45, 95% CI 0.25 to 0.80,
random-effects, T² = 0.00, I² = 0%), silver sulphadiazine (three
studies) (average RR 0.36, 95% CI 0.25 to 0.50, random-effects,
T² = 0.00, I² = 0%), green clay powder (one study) (RR 0.27,
95% CI 0.11 to 0.65) and katoxin powder (one study) (RR 0.26,
95% CI 0.11 to 0.63) (Analysis 4.3). There was no significant dif-
ference in Staphylococcus aureus colonization rates for comparisons
of triple dye versus povidone (RR 0.65, 95% CI 0.03 to 12.87),
triple dye versus salicylic sugar powder (one study) (RR 0.43, 95%
CI 0.16 to 1.12) or triple dye versus fuschine (one study) (RR
1.92, 95% CI 0.18 to 20.97). One trial (Pezzati 2002) studied
alcohol in comparison with green clay powder (RR 0.59, 95% CI
0.30 to 1.16), fuschine (RR 0.57, 95% CI 0.29 to 1.12), salicylic
powder (RR 0.94, 95% CI 0.43 to 2.03) and povidone (RR 0.84,
95% CI 0.62 to 1.16) and found no significant difference in the
colonization of umbilical cord with Staphylococcus aureus.However, treating the umbilical cord with alcohol was associated
with a significant reduction in bacterial colonization with Staphy-lococcus aureus compared with the use of katoxin powder (RR
0.21, 95% CI 0.12 to 0.37, one study). One study each evaluated
chlorhexidine in comparison with hydrophobic gauze (RR 0.90,
95% CI 0.70 to 1.15) and mercurochrome (RR 0.11, 95% CI
0.01 to 2.04) and found no significant difference in colonization
rates for Staphylococcus aureus. There was however, a significant
difference when chlorhexidine was compared with alcohol (two
studies) (RR 0.41, 95% CI 0.24 to 0.71). See (Analysis 4.3).
One study each compared triple dye with alcohol (RR 0.46, 95%
CI 0.04 to 4.94), silver sulphadiazine (RR 1.26, 95% CI 0.71
to 2.25), and fuschine (RR 0.48, 95% CI 0.04 to 5.24) and re-
ported no significant difference between the groups for coloniza-
tion of streptococcus (Analysis 4.4). However, for the same out-
come, there was a significant effect of triple dye compared with
green clay powder (one study) (RR 0.02, 95% CI 0.00 to 0.14),
salicylic sugar powder (one study) (RR 0.12, 95% CI 0.02 to 0.98)
and katoxin powder (one study) (RR 0.02, 95% CI 0.00 to 0.11).
Application of alcohol to the umbilical cord was also associated
with a reduction in colonization of streptococcus compared with
green clay powder (one study) (RR 0.04, 95% CI 0.01 to 0.17)
and katoxin powder (one study) (RR 0.03, 95% CI 0.01 to 0.14)
but there was no difference when alcohol was compared with fus-
chine (one study) (RR 1.05, 95% CI 0.15 to 7.38) or salicylic
powder (one study) (RR 0.94, 95% CI 0.43 to 2.03). See Analysis
4.4.
Triple dye led to an increased risk of colonization of Enterococcuscoli compared with alcohol (one study) (RR 3.44, 95% CI 2.10 to
14Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
5.64), silver sulphadiazine (one study) (RR 1.36, 95% CI 1.02 to
1.81), green clay powder (one study) (RR 1.83, 95% CI 1.27 to
2.65) and salicylic sugar powder (one study) (RR 3.92, 95% CI
2.28 to 6.72) and katoxin powder (one study) (RR 2.07, 95% CI
1.43 to 3.00) (Analysis 4.5). For the same outcomes, alcohol had a
significant preventive effect compared with green clay powder (RR
0.53, 95% CI 0.31 to 0.92) and fuschine (RR 0.33, 95% CI 0.20
to 0.55). However, there was no difference in colonization rates
of Enterococcus coli for the comparison of alcohol with salicylic
powder (one study) (RR 1.14, 95% CI 0.58 to 2.4) and katoxin
powder (one study) (RR 0.60, 95% CI 0.35 to 1.04). Similarly,
there were no differences in colonization rates when comparing
chlorhexidine with hydrophobic gauze (one study) (RR 0.79, 95%
CI 0.31 to 2.00) or mercurochrome (one study) (RR 0.21, 95%
CI 0.01 to 4.13). See Analysis 4.5.
Cord separation time
Cord separation time was not significantly different when triple
dye was compared with alcohol (two studies) (MD 0.43 days, 95%
CI -8.49 to 9.35, random-effects, T² = 40.92, I² = 99%) or when
triple dye was compared with silver sulphadiazine (two studies)
(MD 0.15 days, 95% CI -6.20 to 6.51, random-effects, T² =
18.82, I² = 89%). Cord separation time was increased when triple
dye was compared with salicylic sugar powder (one study) (MD
6.00 days, 95% CI 5.01 to 6.99), povidone-iodine (one study)
(MD 7.60 days, 95% CI 3.96 to 11.24), green clay powder (one
study) (MD 4.90 days, 95% CI 3.92 to 5.88), katoxin powder
(one study) (MD 3.30 days, 95% CI 2.28 to 4.32) and fuschine
(one study) (MD 1.30 days, 95% CI 0.17 to 2.43) (Analysis 4.6).
There was also a significant increase in cord separation time when
the umbilical cord was treated with alcohol compared with green
clay powder (one study) (MD 10.20 days, 95% CI 9.05 to 11.35),
katoxin powder (one study) (MD 8.60 days, 95% CI 7.42 to
9.78), salicylic powder (one study) (MD 11.30 days, 95% CI
10.14 to 12.46) or fuschine (one study) (MD 6.60 days, 95%
CI 5.32 to 7.88) (Analysis 4.6). Chlorhexidine decreased cord
separation time compared with hydrophobic gauze (one study)
(MD -0.40 days, 95% CI -0.57 to -0.23), however, chlorhexidine
significantly increased cord separation time compared with either
salicylic powder (one study) (MD 3.00 days, 95% CI 2.46 to
3.54) or mercurochrome (one study) (MD 6.40 days, 95% CI
5.25 to 7.55) (Analysis 4.6). One study showed that application
of povidone resulted in a shorter cord separation time compared
with silver sulphadiazine (MD -4.00 days, 95% CI -5.53 to -2.47).
However, there was no significant difference in cord separation
time when a combination of triple dye and alcohol was compared
with triple dye alone (MD 1.00 day, 95% CI -0.45 to 2.45). See
Analysis 4.6.
Single versus multiple application of antiseptic
Community studies
There was one study from community settings that compared sin-
gle versus multiple application of chlorhexidine and reported all-
cause mortality, incidence of omphalitis and bacterial coloniza-
tion (Arifeen 2012). No study reported sepsis and tetanus for this
comparison.
Primary outcomes
Mortality
One study (Arifeen 2012) reported data on mortality and there
was no significant difference in all-cause mortality between the
two groups (RR 0.85, 95% CI 0.70 to 1.03] (Analysis 5.1).
Omphalitis
The effect on the incidence of omphalitis varied according to the
severity of omphalitis. Single application was associated with an
increased incidence of moderate (RR 1.53, 95% CI 1.22 to 1.92)
and severe episodes (RR 2.12, 95% CI 1.10 to 4.11) of omphalitis
(Analysis 5.3; Analysis 5.4) compared with multiple applications.
There was no difference between single application and multiple
application groups for mild omphalitis (RR 1.14, 95% CI 0.97 to
1.34 (Analysis 5.2)).
Secondary outcomes
Bacterial colonization
Compared with multiple applications, single application of
chlorhexidine increased the risk of bacterial colonization with
Staphylococcus aureus in one study (RR 3.63, 95% CI 2.74 to 4.82
(Analysis 5.5)) and Enterococcus coli (RR 1.17, 95% CI 1.03 to
1.32 (Analysis 5.7)). For bacterial colonization with streptococcus,
there was no difference between single and multiple application
of chlorhexidine groups in one study (RR 1.01, 95% CI 0.67 to
1.53 (Analysis 5.6)).
Hospital-based studies
Among studies conducted in hospitals settings, no study reported
data for mortality, sepsis, tetanus, omphalitis or bacterial coloniza-
tion.
15Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Secondary outcomes
Cord separation time
Four studies reported data for cord separation time. Among these
studies, three studied triple dye and reported a significant reduc-
tion with single application compared with multiple application
(MD -4.24 days, 95% CI -4.41 to -4.07, random-effects, T² =
0.00, I² = 0% (Analysis 6.1). One study evaluated zinc powder
and showed no difference in cord separation time for single appli-
cation compared with multiple application (MD -0.02 days, 95%
CI -0.31 to 0.27 (Analysis 6.1)).
Washing umbilical cord versus dry cord care
Community studies
One large cluster-randomized community trial (Mullany 2006)
evaluated washing the umbilical cord with soap and water com-
pared with dry cord care. No study reported data on the incidence
of sepsis or tetanus.
Primary outcomes
Mortality
There was no significant difference in all-cause mortality between
the group washing the umbilical cord with soap and water and
the dry cord care group (RR 1.00, 95% CI 0.76 to 1.32 (Analysis
7.1)).
Omphalitis
There was no differential effect of cord washing with soap/water
compared with dry cord care for the incidence of mild (RR 1.03,
95% CI 0.87 to 1.22 (Analysis 7.2)), moderate (RR 0.88, 95%
CI 0.69 to 1.12 (Analysis 7.3)) and severe omphalitis (RR 1.01,
95% CI 0.58 to 1.76 (Analysis 7.4)).
Secondary outcomes
Cord separation time
Cord separation times were similar between the group washing the
umbilical cord with soap and water and the dry cord care group
(MD 0.01 day, 95% CI -0.05 to 0.07 (Analysis 7.5)).
Hospital-based studies
No study reported data for mortality, sepsis, tetanus, omphalitis
and cord separation time.
Secondary outcomes
Bacterial colonization
One study (Rush 1986), was conducted in hospital settings and
reported no significant difference in colonization rates of Staphy-lococcus aureus between the cord washing and dry cord care groups
(RR 0.93, 95% CI 0.65 to 1.34 (Analysis 8.1)).
D I S C U S S I O N
Summary of main results
This review included 34 studies, involving 69,338 babies. Five
further studies are awaiting classification and there are two ongo-
ing community trials. Included studies were conducted in both
developed and developing countries. Among the 34 included tri-
als, three were large, cluster-randomized trials conducted in com-
munity settings in developing countries and 31 studies were con-
ducted in hospital settings mostly in developed countries. Data for
community and hospital studies were analyzed separately. There
were 22 different interventions studied across the included trials;
70% alcohol, triple dye and chlorhexidine were the most com-
monly studied antiseptics in included studies.
Studies conducted in community settings
Combined results of three large, community-based, cluster-ran-
domized trials showed that topical application of chlorhexidine to
umbilical cord stump reduced neonatal mortality and incidence
of omphalitis (Arifeen 2012; Mullany 2006; Soofi 2012). One
study carried out in community-based settings reported microbi-
ologic data and showed that topical application of chlorhexidine
reduces colonization of common pathologic bacteria, which corre-
lates with a reduction in mortality and omphalitis (Arifeen 2012).
There was no difference in mortality reduction with single ver-
sus multiple application of chlorhexidine to umbilical cord, how-
ever, multiple application seems advantageous for the reduction
of omphalitis and bacterial colonization compared with single ap-
plication.Topical application of chlorhexidine may increase cord
separation time by about 1.7 days based on the combined results
of two trials from community settings (Arifeen 2012; Mullany
2006). There was no beneficial effect of washing the umbilical
16Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
cord with soap and water compared with dry cord care for reduc-
tion of mortality, omphalitis and cord separation time (Mullany
2006). Results of one trial showed that there was no advantage of
the promotion of handwashing among caretakers for prevention
of omphalitis and mortality in community settings compared with
control (Soofi 2012).
Studies conducted in hospital settings
Studies conducted in hospital setting were small and had limita-
tions. No study reported data for mortality or tetanus. Triple dye
and alcohol were the most commonly studied antiseptics in hospi-
tal settings. When compared with dry cord care, no antiseptic was
convincingly advantageous to reduce the incidence of omphalitis.
Topical triple dye application reduced bacterial colonization with
Staphylococcus aureus compared with dry cord care and that of alco-
hol application (two separate analyses). There was no advantage of
application of alcohol and triple dye for reduction of colonization
with streptococcus. Topical alcohol application was advantageous
for the reduction of colonization with Enterococcus coli compared
with dry cord care and triple dye application (two separate anal-
yses). Topical application of alcohol and triple dye increased cord
separation time compared with dry cord care in hospital settings.
When triple dye was compared with alcohol, no significant dif-
ference was noticed in the incidence of omphalitis and cord sep-
aration time. Single application of triple dye was associated with
a decrease in cord separation time compared with multiple appli-
cation. Washing the cord was not advantageous compared with
dry cord care. The number of studies was insufficient to make an
inference about the efficacy of other antiseptics.
Overall completeness and applicability ofevidence
Studies conducted in community settings
Three large, well-conducted, cluster-randomized, community tri-
als reported data on the effectiveness of topical application of
chlorhexidine for prevention of mortality and omphalitis. The ag-
gregated sample size of these trials involved 78% of the 69,338
babies included in this review. Pooled results for all-cause mor-
tality showed a significant reduction of 23% in the intervention
group compared with control. The statistical heterogeneity for this
comparison was significant (I2 = 50%). The likely reasons for this
statistical heterogeneity could be the difference in mortality rates
in control populations of included studies and the diversity in
topical application of materials other than antiseptics such as ash,
surma (a lead-based preparation Soofi 2012), mud, mustard oil
and even cow dung. The mortality in the control group was 36.1/
1000 in Soofi 2012, 28.3/1000 in Arifeen 2012 and 19.3/1000 in
Mullany 2006. The reduction in the incidence of omphalitis was
also significant and was more prominent for severe cases. Data on
reduction of bacterial colonization reported by one trial (Arifeen
2012) correlated with the reduction in mortality and omphalitis.
Cord separation time may be slightly increased with application
of chlorhexidine, however, there was no increased risk of mortal-
ity or omphalitis as discussed by authors in the study by Mullany
2006.These findings suggest that there is significant evidence to
recommend topical application of chlorhexidine in community
settings for prevention of mortality and omphalitis.
Studies conducted in hospital settings
Most of the studies conducted in hospital settings were small and
had limitations. The sample size ranged between 71 and 2241.
There were no studies conducted in hospital settings that reported
mortality or tetanus. Compared with dry cord care, no antisep-
tic was advantageous to prevent omphalitis. The most commonly
studied antiseptics were alcohol and triple dye. Both of them re-
duced bacterial colonization but there are no data to show that
this decrease in bacterial colonization converts into prevention
of clinical outcomes of mortality, sepsis, tetanus or omphalitis.
Cord separation time may increase with application of alcohol and
triple dye. In summary, there is no convincing evidence to recom-
mend an antiseptic in hospital settings compared with dry cord
care. Most of the hospital-based studies were conducted in devel-
oped countries. The lack of protective effect of antiseptics may be
correlated with better hygiene at the time of birth and later care
of babies in newborn nurseries. It is also likely that most of the
hospital-based deliveries were planned and mothers were getting
regular prenatal care. The chances of getting therapeutic care for
perinatal infections are also greater with hospital-based deliveries.
It may thus be correlated that the overall risk of infection is low
in hospital-based deliveries in developed countries compared with
community-based deliveries in developing countries and thus the
apparent protective effect of chlorhexidine in community studies.
Quality of the evidence
Figure 1 summarizes the risk of bias in the studies. Most of the
studies included in this review had a moderate risk of bias. The
overall risk of bias is summarized in Figure 2.
17Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Studies conducted in community settings were large and were at
low risk of bias. Pooled data showed a moderate amount of statis-
tical heterogeneity that could be expected because of the baseline
difference in study settings, topical application of other substances
and baseline mortality.
Studies conducted in hospital settings were small and had out-
comes that did not have clinical significance. No study reported
data on mortality or tetanus.
Potential biases in the review process
This review used clearly specified inclusion and exclusion crite-
ria and a comprehensive search strategy for the identification of
relevant studies. The post-hoc decision to include studies on all
antiseptics for umbilical cord care is noted in Differences between
protocol and review. This decision was made to include all avail-
able evidence on umbilical cord care. Studies conducted in hospital
and community studies were analysed separately because the risk
factors for umbilical cord infection may differ between hospital
and community settings. The comprehensive search strategy was
devised to minimize publication bias by searching for both pub-
lished and unpublished studies. While studies with positive results
are more likely to be published than studies with negative results,
studies large enough to make a difference in this review are very
likely to be published. Pre-specified subgroup analyses for gesta-
tional age and geographic location were not performed because
there were insufficient studies to make a conclusive comparison.
The three community trials involved 10 individual study groups
that tested different frequencies and durations of chlorhexidine
application along with other interventions such as washing the
cord with soap and water (Mullany 2006) and promotion of hand-
washing among caretakers (Soofi 2012). There was no differential
effect of interventions other than topical chlorhexidine applica-
tion. In order to examine whether chlorhexidine has any protec-
tive effect, all the chlorhexidine groups were combined and com-
pared with non-chlorhexidine groups. This combination of study
groups is not expected to bias the results as the soap/water group
in Mullany 2006 had an effect size very similar to control, i.e. dry
cord care. Soofi 2012 was a factorial design trial and we included
the factorial analyses in which handwashing groups were balanced
between the two study groups (chlorhexidine + handwashing plus
chlorhexidine only versus handwashing only plus dry cord care).
Arifeen 2012 had two chlorhexidine groups, i.e. seven-day and
one-day application. These were combined to include chlorhexi-
dine groups in one arm and compared it with dry cord care.
Random-effects models were used for all meta-analyses. There are
no comprehensive rules on when to use random-effects or fixed-
effect models for meta-analysis (Higgins 2011). The difference
between two models is that a fixed-effect model assumes that ob-
served differences between results of trials is due to sampling vari-
ation of individual studies only whereas a random-effects model
assumes that outcomes of trials might differ both because of sam-
pling variation of individual studies and true diversity in effects.
Both models can be appropriately applied for pooling data but a
random-effects model is usually preferred with heterogeneity. We
used random-effects models because there was substantial hetero-
geneity across studies in study design, settings, and package of in-
terventions and/or intensity of delivery of those interventions.
Agreements and disagreements with otherstudies or reviews
The only comprehensive review on umbilical cord care was by Zu-
pan et al that was first published in 1998. The most updated ver-
18Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
sion (Zupan 2004) came to conclusion that there are not enough
data to recommend in favour of or against an antiseptic for um-
bilical cord care. Most of the included studies were small and con-
ducted in hospital settings. Results of our review are in agreement
with those of Zupan 2004 for studies conducted in hospital set-
tings with the addition of the effectiveness of chlorhexidine to
reduce mortality and morbidity in community settings. We have
not only included studies from community settings but have also
included more studies from hospital settings. The updated analy-
ses did not change the results for hospital-based studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is significant evidence to suggest that topical application of
chlorhexidine to umbilical cord reduces neonatal mortality and
omphalitis in community and primary care settings in developing
countries. It may increase cord separation time however there is no
evidence that it increases subsequent risk of mortality or infection.
There is not sufficient evidence to support the application of an
antiseptic to umbilical cord in hospital settings compared with dry
cord care in developed countries.
Implications for research
More studies are needed to explore the effects of antiseptics in
hospital settings with clinically important outcomes of mortality,
sepsis, tetanus and omphalitis. Studies should be undertaken in a
range of settings and should account for differences in outcomes
among different gestational ages.
Three community trials were conducted in South Asia. Further
trials should be conducted in other parts of the world to replicate
the results. Further evaluation of the effectiveness of chlorhexi-
dine should be performed in the context of interventions pack-
aged to facilitate their delivery by health systems. Such packages
may include a wide range of interventions to reduce perinatal and
neonatal mortality, such as clean delivery practices, breastfeeding,
mother/infant skin-to-skin care, and delayed bathing.
A C K N O W L E D G E M E N T S
We would like to acknowledge Professor Lourdes Amarillo and
Professor Cynthia Cordero for their statistical contributions.
We also thank Sara Roden-Scott for her translation of Davila 2007.
We would like to give special thanks to Sonja Henderson from
Pregnancy and Childbirth Cochrane Review Group for her con-
tinuous support and co-ordination during the conduct of this re-
view.
The National Institute for Health Research (NIHR) is the largest
single funder of the Cochrane Pregnancy and Childbirth Group.
The views and opinions expressed therein are those of the authors
and do not necessarily reflect those of the NIHR, NHS or the
Department of Health.
R E F E R E N C E S
References to studies included in this review
Ahmadpour-Kacho 2006 {published data only}
Ahmadpour-Kacho M, Zahedpasha Y, Hajian K, Javadi
G, Talebian H. The effect of topical application of human
milk, ethyl alcohol 96%, and silver sulfadiazine on umbilical
cord separation time in newborn infants. Archives of Iranian
Medicine 2006;9:33–8.
Al-Binali 2006 {published data only}
Al-Binali AM. Umbilical cord care: comparison between
Beniktol spray and alcohol swab. Biomedical Research 2006;
17(1):23–5.
Arad 1981 {published data only}
Arad I, Eyal F, Fainmesser P. Umbilical care and cord
separation. Archives of Disease in Childhood 1981;56:887–8.
Arifeen 2012 {published data only}∗ Arifeen SE, Mullany LC, Shah R, Mannan I, Rahman
SM, Talukder MRR, et al.Impact of cord cleansing with
chlorhexidine on neonatal mortality in rural Bangladesh: a
community-based, cluster-randomised trial. Lancet 2012;
379(9820):1022–8.
Bacqui AH. Impact of umbilical cord cleansing with
4.0% chlorhexidine on neonatal mortality (CHX).
ClinicalTrials.gov (http://clinicaltrials.gov/show/
NCT00434408) 2010.
Mullany LC, El Arifeen S, Winch PJ, Shah R, Mannan I,
Rahman SM, et al.Impact of 4.0% chlorhexidine cleansing
of the umbilical cord on mortality and omphalitis among
newborns of Sylhet, Bangladesh: design of a community-
based cluster randomized trial. BMC Pediatrics 2009;9:67.
Mullany LC, Khatry SK, Sherchand JB, LeClerq SC,
Darmstadt GL, Katz J, et al.A randomized controlled trial
of the impact of chlorhexidine skin cleansing on bacterial
colonization of hospital-born infants in Nepal. Pediatric
Infectious Disease Journal 2008;27(6):505–11.
Mullany LC, Saha SK, Shah R, Islam MS, Rahman M,
Islam M, et al.Impact of 4.0% chlorhexidine cord cleansing
on the bacteriologic profile of the newborn umbilical stump
in rural sylhet district, Bangladesh: A community-based,
19Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
cluster-randomized trial. Pediatric Infectious Disease Journal
2012;31(5):444–50.
Bain 1994 {published data only}
Bain J. Midwifery: umbilical cord care in pre-term babies.
Nursing Standard 1994;8(15):32–6.
Barrett 1979 {published data only}
Barrett FF, Mason EO, Fleming D. The effect of three cord-
care regimens on bacterial colonization of normal newborn
infants. Journal of Pediatrics 1979;94:796–800.
Davila 2007 {published data only}
Davila GR, Pomar JV, Meza EQ, Villanueva CQ, Serkovic
KR, Jordan FR, et al.Umbilical cord care: effect of three
different antiseptic solutions (clorhexidine 4 per cent,
alcohol 70 per cent and iodo povidone 5 per cent) on
bacterial colonization, infection and cord separation time
[Cuidados del cordón umbilical: efecto de tres soluciones
antisépticas (gluconato de clorhexidina al 4 por ciento,
alcohol al 70 por ciento y yodopovidona al 5 por ciento)
sobre la colonización bacteriana, infección y separación del
muñón umbilical]. Revista Peruana de Pediatria 2007;60
(2):81–7.
Dore 1998 {published data only}
Dore S, Buchan D, Coulas S, Hamber L, Stewart M, Cowan
D, et al.Alcohol versus natural drying for newborn cord
care. Journal of Obstetric, Gynecologic and Neonatal Nursing
1998;27(6):621–7.
Evens 2004 {published data only}∗ Evens K, George J, Angst D, Schweig L. Does umbilical
cord care in preterm infants influence cord bacterial
colonization or detachment?. Journal of Perinatology 2004;
24:100–4.
Evens KH, George J, Angst DB, Schweig L. Does umbilical
cord care in preterm infants influence cord colonization
and/or detachment. Pediatric Academic Societies Annual
Meeting; 2003 May 1-4; Seattle, Washington, USA. 2003.
Gladstone 1988 {published data only}
Gladstone IM, Clapper L, Thorp JW, Wright DI.
Randomized study of six umbilical cord care regimens.
Comparing length of attachment, microbial control, and
satisfaction. Clinical Pediatrics 1988;27:127–9.
Golombek 2002 {published data only}
Golombek SG, Brill PE, Salice AL. Randomized trial of
alcohol versus triple dye for umbilical cord care. Clinical
Pediatrics 2002;41(6):419–23.
Hsu 1999 {published data only}
Hsu CF, Wang CC, Yuh YS, Chen YH, Chu ML. The
effectiveness of single and multiple applications of triple
dye on umbilical cord separation time. European Journal of
Pediatrics 1999;158:144–6.
Hsu 2010 {published data only}
Hsu WC, Yeh LC, Chuang MY, Lo WT, Cheng SN,
Huang CF. Umbilical separation time delayed by alcohol
application. Annals of Tropical Paediatrics 2010; Vol. 30,
issue 3:219–23.
Huang 2001 {published data only}
Huang CF, Yeh LC, Chuang MY, Yuh YS. Umbilical
separation time delayed by alcohol application. Journal of
Perinatal Medicine 2001;29 Suppl 1(Pt 2):648.
Janssen 2003 {published data only}
Janssen PA, Selwood BL, Dobson SR, Peacock D, Theissen
PN. To dye or not to dye: a randomized, clinical trial of a
triple dye/alcohol regime versus dry cord care. Pediatrics
2003;111:15–20.
Kapellen 2009 {published data only}∗ Kapellen TM, Gebauer CM, Brosteanu O, Labitzke B,
Vogtmann C, Kiess W. Higher rate of cord-related adverse
events in neonates with dry umbilical cord care compared to
chlorhexidine powder. Results of a randomized controlled
study to compare efficacy and safety of chlorhexidine
powder versus dry care in umbilical cord care of the
newborn. Neonatology 2009;96(1):13–8.
Vogtmann C. A randomised controlled study to compare
efficacy and safety of chlorhexidine powder versus dry
care in umbilical cord care of the newborn. Current
Controlled Trials (http://www.controlled-trials.com/
ISRCTN63012285/) (accessed 2010).
Meberg 1985 {published data only}
Meberg A, Schoyen R. Bacterial colonization and neonatal
infections. Effects of skin and umbilical disinfection in the
nursery. Acta Paediatrica Scandinavica 1985;74:366–71.
Meberg 1990 {published data only}
Meberg A, Schoyen R. Hydrophobic material in routine
umbilical cord care and prevention of infections in newborn
infants. Scandinavian Journal of Infectious Diseases 1990;22:
729–33.
Medves 1997 {published data only}
Medves JM, O’Brien BA. Cleaning solutions and bacterial
colonization in promoting healing and early separation of
the umbilical cord in healthy newborns. Canadian Journal
of Public Health 1997;88(6):380–2.
Mugford 1986 {published data only}
Mugford M, Somchiwong M, Waterhouse IL. Treatment
of umbilical cords: a randomised trial to assess the effect of
treatment methods on the work of midwives. MIdwifery
1986;2:177–86.
Mullany 2006 {published data only}∗ Mullany LC, Darmstadt GL, Khatry SK, Katz J, LeClerq
SC, Shrestha S, et al.Topical applications of chlorhexidine
to the umbilical cord for prevention of omphalitis and
neonatal mortality in southern Nepal: a community-based,
cluster-randomised trial. Lancet 2006;367(9514):910–8.
Mullany LC, Darmstadt GL, Khatry SK, LeClerq SC, Katz
J, Tielsch JM. Impact of umbilical cord cleansing with 4.0%
chlorhexidine on time to cord separation among newborns
in southern Nepal: a cluster-randomized, community-based
trial. Pediatrics 2006;118(5):1864–71.
Nourian 2009 {published data only}
Nourian M, Allaii F, Heidari A. Comparison of the effect
of alcohol 70% versus dry cord care on cord bacterial
20Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
colonization and cord separation time among newborns.
Pakistan Journal of Medical Sciences 2009;25(1):103–7.
Oishi 2004 {published data only}
Oishi T, Iwata S, Nonoyama M, Tsuji A, Sunakawa
K. Double-blind comparative study on the care of the
neonatal umbilical cord using 80% ethanol with or without
chlorhexidine. Journal of Hospital Infection 2004;58:34–7.
Panyavudhikrai 2002 {published data only}
Panyavudhikrai S, Danchaivijitr S, Vantanasiri C,
Trakulsomboon S, Kolatat T, Dhiraputra C, et al.Antiseptics
for preventing omphalitis. Journal of the Medical Association
of Thailand 2002;85:229–34.
Perapoch 1993 {published data only}
Perapoch Lopez J, Salcedo Abizanda S, Gallart Catala A,
Peguero Monforte G, Casellas Caro M, Barroso Perez
C, et al.Umbilical colonization in normal newborns. A
comparative study of 4 methods for umbilical antisepsis
[Colonizacion umbilical en recien nacidos normales:
Estudio comparativo de cuatro metodos de antisepsia
umbilical]. Anales Espanoles de Pediatria 1993;39:195–8.
Pezzati 2002 {published data only}
Pezzati M, Biagoli EC, Martelli E, Gambi B, Biagiotti
R, Rubaltelli FF. Umbilical cord care: the effect of eight
different cord-care regimens on cord separation time and
other outcomes. Biology of the Neonate 2002;81:38–44.
Pezzati 2003 {published data only}
Pezzati M, Rossi S, Tronchin M, Dani C, Filippi L,
Rubaltelli FF. Umbilical cord care in premature infants: the
effect of two different cord-care regimens (salicylic sugar
powder vs chlorhexidine) on cord separation time and other
outcomes. Pediatrics 2003;112(4):e275.
Rosenfeld 1989 {published data only}
Rosenfeld CR, Laptook AR, Jeffery J. Limited effectiveness
of triple dye (TD) in prevention of colonization with
methacillin resistant staphylococcus aureus (MRSA) in a
special care nursery (SCN). Pediatric Research 1989;25:
281A.
Rush 1986 {published data only}
Rush J. Does routine newborn bathing reduce
staphylococcus aureus colonization rates? A randomized
controlled trial. Birth 1986;13:176–80.
Schuman 1985 {published data only}
Schuman AJ, Oksol BA. The effect of isopropyl alcohol
and triple dye on umbilical cord separation time. Military
Medicine 1985;150:49–50.
Shafique 2006 {published data only}
Shafique MF, Ali S, Roshan E, Jamal S. Alcohol application
versus natural drying of umbilical cord. Rawal Medical
Journal 2006;31(2):58–60.
Soofi 2012 {published data only}
Bhutta Z. Topical application of chlorhexidine to the
umbilical cord for prevention of omphalitis and neonatal
mortality in rural distract of Pakistan. ClinicalTrials.gov
(http://clinicaltrials.gov/ct2/show/NCT00682006)
(accessed May 2010).∗ Soofi S, Cousens S, Imdad A, Bhutto N, Ali N, Bhutta
ZA. Topical application of chlorhexidine to neonatal
umbilical cords for prevention of omphalitis and neonatal
mortality in a rural district of Pakistan: a community-based,
cluster-randomised trial. Lancet 2012;379(9820):1029–36.
Speck 1977 {published data only}
Speck WT, Driscoll JM, O’Neill J, Rosenkranz HS. Effect
of antiseptic cord care on bacterial colonization in the
newborn infant. Chemotherapy 1980;26:372–6.∗ Speck WT, Driscoll JM, Polin RA, O’Neill J, Rosenkraz
HS. Staphylococcal and streptococcal colonization of the
newborn infant: effect of antiseptic cord care. American
Journal of Diseases of Children 1977;131:1005–8.
Speck WT, Driscoll JM, Polin RA, Rosenkranz HS.
Bacterial colonization in the newborn - effect of cord care.
Pediatric Research 1976;10:335.
Suliman 2010 {published data only}
Beiler J. Triple dye plus alcohol versus triple dye alone for
newborn umbilical cord care. ClinicalTrials.gov (http://
clinicaltrials.gov/) (accessed 21 March 2006).∗ Suliman AK, Watts H, Beiler J, King TS, Khan S,
Carnuccio M, et al.Triple dye plus rubbing alcohol versus
triple dye alone for umbilical cord care. Clinical Pediatrics
2010;49(1):45–8.
Suliman AK, Watts HN, Beiler JS, King TS, Khan S,
Carnuccio MB, et al.Triple dye plus rubbing alcohol versus
triple dye alone in umbilical cord care. Pediatric Academic
Societies Annual Meeting; 2007 May 5-8; Toronto, Canada.
2007.
References to studies excluded from this review
Alda 2000 {published data only}
Alda ER, Covas MC, Ventura SS, Baeza AM. Umbilical
cord bacterial growth in healthy newborn with two different
antiseptics. Pediatric Research 2000;47:385A.
Aldar 1980 {published data only}
Alder VG, Burman D, Simpson RA, Fysh J, Gillespie
WA. Comparison of hexachlorophane and chlorhexidine
powders in prevention of neonatal infection. Archives of
Disease in Childhood 1980;55:277–80.
Barclay 1994 {published data only}
Barclay L, Harrington A, Conroy R, Royal R, LaForgia J. A
comparative study of neonates’ umbilical cord management.
Australian Journal of Advanced Nursing 1994;11:34–40.
Bhakoo 1969 {published data only}
Bhakoo ON, Lall JC, Agarwal KC. Prevention of hospital
infections in neonates: an evaluation of no bath regimen.
Indian Pediatrics 1969;6:697–700.
Birenbaum 1990 {published data only}
Birenbaum HJ, Glorioso L, Rosenberger C, Arshad C,
Edwards K. Gowning on a postpartum ward fails to decrease
colonization in the newborn infant. American Journal of
Diseases of Children 1990;144:1031–3.
21Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bourke 1989 {published data only}
Bourke E. Cord care: too much or too little. Australian
Journal of Advanced Nursing 1990;7(2):19–22.
Bradshaw 1993 {published data only}
Bradshaw C. An experimental study to compare treatment vs
non treatment of the umbilical cord. National Conference
on Research in Midwifery; 1993 Sept 14; Birmingham, UK.
1993.
Chamnanvanakij 2005 {published data only}
Chamnanvanakij S, Decharachakul K, Rasamimaree P,
Vanprapar N. A randomised study of 3 umbilical cord care
regimens at home in Thai neonates: comparison of time to
umbilical cord separation, parental satisfaction and bacterial
colonization. Journal of the Medical Association of Thailand
2005;88(7):967–72.
Coyer 1975 {published data only}
Coyer WF. Neonatal skin care and the prevention of
staphylococcus aureus (staph) colonization. Pediatric
Research 1975;9:339.
Darmstadt 2007 {published data only}
Darmstadt GL, Hossain MM, Choi Y, Shirin M, Mullany
LC, Islam M, et al.Safety and effect of chlorhexidine skin
cleansing on skin flora of neonates in Bangladesh. Pediatric
Infectious Disease Journal 2007;26(6):492–5.
Erenel 2010 {published data only}
Erenel AS, Vural G, Efe SY, Ozkan S, Ozgen S, Erenoglu R.
Comparison of olive oil and dry-clean keeping methods in
umbilical cord care as microbiological. Maternal & Child
Health Journal 2010;14(6):999–1004.
Gezon 1964 {published data only}
Gezon HM, Thompson DJ, Rogers KD, Hatch TF, Taylor
PM. Hexachlorophene bathing in early infancy. New
England Journal of Medicine 1964;270(8):379–6.
Gluck 1963 {published data only}
Gluck L, Wood HF. Staphylococcal colonization in
newborn infants with and without antiseptic skin care. A
consideration of epidemiologic routes. New England Journal
of Medicine 1963;268:1265–8.
Guala 2003 {published data only}
Guala A, Pastore G, Garipoli V, Agosti M, Vitali M, Bona
G. The time of umbilical cord separation in healthy full-
term newborns: a controlled clinical trial of different cord
care practices. European Journal of Pediatrics 2003;162(5):
350–1.
Guinsburg 1991 {published data only}
Guinsburg R, Ikezawa MK, Fogliano RRF, Reichert
MCF, Carvalho ES, Cardo DM, et al.Umbilical bacterial
colonization (UBC) of normal newborn (NB) infants:
effect of four antiseptic regimens. Pediatric Research 1991;
29:282A.
Healey 1991 {published data only}
Healey E, Greenish K, Armstrong C, Ayers S. A study of the
relationship between the delivery to cord clamping interval
and the time of cord separation. Midwifery 1991;7:167–76.
Henningsson 1981 {published data only}
Henningsson A, Nystrom B, Tunnell R. Bathing or washing
babies after birth?. Lancet 1981;2:1401–3.
Hnatko 1977 {published data only}
Hnatko SI. Alternatives to hexachlorophene bathing of
newborn infants. Canadian Medical Association Journal
1977;117:223–6.
Hodgins 2010 {published data only}
Hodgins S, Thapa K, Khanal L, Aryal S, Suvedi BK, Baidya
U, et al.Chlorhexidine gel versus aqueous for preventive
use on umbilical stump: a randomized noninferiority trial.
Pediatric Infectious Disease Journal 2010;29(11):999–1003.
Jellard 1957 {published data only}
Jellard J. Umbilical cord as reservoir of infection in a
maternity hospital. BMJ 1977;1(5024):925–8.
Kumar 2008 {published data only}
Kumar V, Mohanty S, Kumar A, Misra RP, Santosham
M, Awasthi S, et al.Effect of community-based behaviour
change management on neonatal mortality in Shivgarh,
Uttar Pradesh, India: a cluster-randomised controlled trial.
Lancet 2008;372(9644):1151–62.
Kwong 1973 {published data only}
Kwong MS, Loew AD, Anthony BF, Oh W. The effect of
hexachlorophene on staphylococcal colonization rates in
the newborn infant: a controlled study using a single-bath
method. Journal of Pediatrics 1973;82:982–6.
Olowe 1980 {published data only}
Olowe SA, Ransome-Kuti O. The risk of jaundice in
glucose-6-phosphate dehydrogenase deficient babies
exposed to menthol. Acta Paediatrica Scandinavica 1980;
69:341–5.
Pildes 1973 {published data only}
Pildes RS, Ramamurthy RS, Vidyasagar D. Effect of triple
dye on staphylococcal colonization in the newborn infant.
Journal of Pediatrics 1973;82:987–90.
Pyati 1977 {published data only}
Pyati SP, Ramamurthy RS, Krauss MT, Pildes RS.
Absorption of iodine in the neonate following topical use of
povidone iodine. Journal of Pediatrics 1977;91(5):825–8.
Ronchera-Oms 1994 {published data only}
Ronchera-Oms C, Hernandez C, Jimenez NV. Antiseptic
cord care reduces bacterial colonisation but delays cord
detachment. Archives of Disease in Childhood. Fetal and
Neonatal Edition 1994;70:F70.
Saleem 2007 {published data only}
Saleem S, Reza T, McClure EM, Pasha O, Moss N, Rouse
DJ, et al.Chlorhexidine vaginal and neonatal wipes in home
births in Pakistan: a randomized controlled trial. Obstetrics
and Gynecology 2007;110(5):977–85.
Saleem 2010 {published data only}
Saleem S, Rouse DJ, McClure EM, Zaidi A, Reza T, Yahya
Y, et al.Chlorhexidine vaginal and infant wipes to reduce
perinatal mortality and morbidity: a randomized controlled
trial. Obstetrics and Gynecology 2010;115(6):1225–32.
22Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Shah 2010 {published data only}
Shah R, Munos MK, Winch PJ, Mullany LC, Mannan
I, Rahman SM, et al.Community-based health workers
achieve high coverage in neonatal intervention trials: a case
study from Sylhet, Bangladesh. Journal of Health, Population
& Nutrition 2010;28(6):610–8.
Smales 1988 {published data only}
Smales O. A comparison of umbilical cord treatment in
the control of superficial infection. New Zealand Medical
Journal 1988;101:453–5.
Tielsch 2006 {published data only}
Tielsch JM. Community trial of newborn skin and
umbilical cord cleansing on neonatal mortality in Nepal.
ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 2006)
2006.
Tielsch 2007 {published data only}
Tielsch JM, Darmstadt GL, Mullany LC, Khatry SK, Katz
J, LeClerq SC, et al.Impact of newborn skin-cleansing with
chlorhexidine on neonatal mortality in Southern Nepal:
a community-based, cluster-randomized trial. Pediatrics
2007;119(2):e330–e340.
Wade 2006 {published data only}
Wade A, Osrin D, Shrestha BP, Sen A, Morrison J,
Tumbahangphe KM, et al.Behaviour change in perinatal
care practices among rural women exposed to a women’s
group intervention in Nepal. BMC Pregnancy and
Childbirth 2006;6:20.
Wald 1977 {published data only}
Wald ER, Snyder MJ, Gutberlet RL. Group B beta-
hemolytic streptococcal colonization. Acquisition,
persistence, and effect of umbilical cord treatment with
triple dye. American Journal of Diseases of Children 1977;
131:178–80.
Watkinson 1992 {published data only}
Watkinson M, Dyas A. Staphylococcus aureus still colonizes
the untreated neonatal umbilicus. Journal of Hospital
Infection 1992;21:131–6.
Wojciechowska 1989 {published data only}
Wojciechowska L. Trial to assess the effects of different
treatments of the umbilical cord in newborn infants.
Personal communication 1989.
References to studies awaiting assessment
Covas 2011 {published data only}
Covas MC, Alda ER, Medina MS, Ventura S, Esandi ME,
Pezutti O, et al.Alcohol versus bath and natural drying
for term newborns’ umbilical cord care: a prospective
randomized clinical trial. Pediatric Academic Societies
Annual Meeting; 2010 May 1-4; Vancouver, Canada. 2010.∗ Covas Mdel C, Alda E, Medina MS, Ventura S, Pezutti
O, Paris de Baeza A, et al.Alcohol versus bath and
natural drying for term newborns’ umbilical cord care: A
prospective randomized clinical trial [Spanish]. Archivos
Argentinos de Pediatria 2011;109(4):305–13.
Nasrallah 2003 {published data only}
Nasrallah BK, Rox AK, Mazer B, Richards L, Chuachingco
J, Naqvi M. Comparison of two methods of umbilical cord
care: application of 70% isopropyl alcohol vs. natural
drying. Pediatric Academic Societies Annual Meeting; 2003
May 1-4; Seattle Washington, USA. 2003.
Sellares Casas 2002 {published data only}
Sellares Casas E, Yanez Juan A, Lopez de Aguileta Ibisate A,
Peix Sambola MA, Esteva Nuto N, Domenech Terricabras
P. Efficacy of one versus three applications of merbromin in
achieving umbilical cord detachment [Spanish] [Efficacia
de una aplicacion frente a tres de merbromina en el tiempo
de caida del cordon]. Acta Pediatrica Espanola 2002;60(9):
521–5.
Srinivasan 2003 {published data only}
Srinivasan H, Luayon M, Barrios F, Geraldo V, Poladian A,
Reyes J, et al.Prospective randomized controlled trial to
study the effect of daily application of triple dye to umbilical
cord of very low birth weight (VLBW) infants. Pediatric
Academic Societies Annual Meeting; 2003 May 1-4; Seattle,
Washington. 2003.
Taffazoli 2008 {published data only}
Taffazoli M, Farahani LA, Mohammadzadeh A, Esmaeeli H,
Ghazvini K. Does topical application of breast milk affect
on bacterial colonization in umbilical cord?. Koomesh 2008;
10(1):29–35.
References to ongoing studies
Hamer 2010 {published data only}∗ Hamer DH. Zambia Chlorhexidine Application Trial
(ZamCAT). Clinicaltrials.gov (http://clinicaltrials.gov)
(accessed 2010) 2010.
Herlihy JM, Semrau K, Mazimba A, Yeboah-Antwi K,
Grogan C, Banda B, et al.Chlorhexidine 4% umbilical
wash lengthens time to cord separation. Pediatric Academic
Societies Annual Meeting 2012 April 29-May 1; Boston,
USA. 2012.
Sazawal 2012 {published data only}
Sazawal S. Chlorhexidine cordcare for reduction in neonatal
mortality and omphalitis (CHX-Pemba). ClinicalTrials.gov
2012.
Additional references
AAP 2003
AAP Committee on Infectious Diseases. Red Book: a Report
of the Committee on Infectious Diseases. 26th Edition. Elk
Grove Village, IL: American Academy of Pediatrics, 2003.
Aggett 1981
Aggett PJ, Cooper LV, Ellis SH, McAinsh J. Percutaneous
absorption of chlorhexidine in neonatal cord care. Archives
of Disease in Childhood 1981;56(11):878–80.
Agrawal 2012
Agrawal PK, Agrawal S, Mullany LC, Darmstadt GL,
Kumar V, Kiran U, et al.Clean cord care practices and
neonatal mortality: evidence from rural Uttar Pradesh,
23Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
India. Journal of Epidemiology and Community Health 2012;
66(8):755–8.
Bennett 1997
Bennett J, Macia J, Traverso H, Banoagha S, Malooly C,
Boring J. Protective effects of topical antimicrobials against
neonatal tetanus. International Journal of Epidemiology
1997;26(4):897–903.
Blencowe 2011
Blencowe H, Cousens S, Mullany LC, Lee AC, Kerber K,
Wall S, et al.Clean birth and postnatal care practices to
reduce neonatal deaths from sepsis and tetanus: a systematic
review and Delphi estimation of mortality effect. BMC
Public Health 2011;11 Suppl 3:S11.
Darmstadt 2009
Darmstadt GL, Lee AC, Cousens S, Sibley L, Bhutta ZA,
Donnay F, et al.60 Million non-facility births: who can
deliver in community settings to reduce intrapartum-related
deaths?. International Journal of Gynaecology and Obstetrics
2009;107(Suppl 1):S89–S112.
Elhassani 1984
Elhassani SB. The umbilical cord: care, anomalies, and
diseases. Southern Medical Journal 1984;77(6):730–6.
Fairchild 1958
Fairchild JP, Graber CD, Vogel EH, Jr, Ingersoll RL,
Ingersoll RL. Flora of the umbilical stump; 2,479 cultures.
Journal of Pediatrics 1958;53(5):538–46.
Faridi 1993
Faridi MM, Rattan A, Ahmad SH. Omphalitis neonatorum.
Journal of the Indian Medical Association 1993;91(11):
283–5.
Forshall 1957
Forshall I. Septic umbilical arteritis. Archives of Disease in
Childhood 1957;32(161):25–30.
Gallagher 2010
Gallagher PG. Omphalitis. eMedicine (http://
emedicine.medscape.com/) (accessed April 14 2010) 2010.
Higgins 2011
Higgins JPT, Green S, editors. Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 [updated
March 2011]. The Cochrane Collaboration, 2011.
Available from www.cochrane-handbook.org.
Johnsson 1987
Johnsson J, Seeberg S, Kjellmer I. Blood concentrations of
chlorhexidine in neonates undergoing routine cord care
with 4% chlorhexidine gluconate solution. Acta Paediatrica
Scandinavica 1987;76(4):675–6.
Lawn 2005
Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths:
when? where? why?. Lancet 2005;365(9462):891–900.
Lehmann 1999
Lehmann D, Michael A, Omena M, Clegg A, Lupiwa T,
Sanders RC, et al.The bacterial and viral etiology of severe
infection in children aged less than three months in the
highlands of Papua New Guinea. Pediatric Infectious Disease
Journal 1999;18(10 Suppl):S42–S49.
Liu 2012
Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et
al.Global, regional, and national causes of child mortality:
an updated systematic analysis for 2010 with time trends
since. Lancet 2012;379(9832):2151–61.
Mason 1989
Mason WH, Andrews R, Ross LA, Wright HT Jr.
Omphalitis in the newborn infant. Pediatric Infectious
Disease Journal 1989;5:521–5.
McClure 2007
McClure EM, Goldenberg RL, Brandes N, Darmstadt GL,
Wright LL, Armbruster D, et al.The use of chlorhexidine to
reduce maternal and neonatal mortality and morbidity in
low-resource settings. International Journal of Gynaecology
and Obstetrics 2007;97(2):89–94.
McKenna 1977
McKenna H, Johnson D. Bacteria in neonatal omphalitis.
Pathology 1977;9(2):111–3.
Mir 2011
Mir F, Tikmani SS, Shakoor S, Warraich HJ, Sultana S, Ali
SA, et al.Incidence and etiology of omphalitis in Pakistan:
a community-based cohort study. Journal of Infection in
Developing Countries 2011;5(12):828–33.
Mullany 2006a
Mullany LC, Darmstadt GL, Katz J, Khatry SK, LeClerq
SC, Adhikari RK, et al.Development of clinical sign based
algorithms for community based assessment of omphalitis.
Archives of Disease in Childhood. Fetal and Neonatal Edition
2006;91(2):F99–104.
Mullany 2006b
Mullany LC, Darmstadt GL, Khatry SK, LeClerq SC, Katz
J, Tielsch JM. Impact of umbilical cord cleansing with 4.0%
chlorhexidine on time to cord separation among newborns
in southern Nepal: a cluster-randomized, community-based
trial. Pediatrics 2006;118(5):1864–71.
Mullany 2007
Mullany LC, Darmstadt GL, Katz J, Khatry SK, LeClerq
SC, Adhikari RK, et al.Risk factors for umbilical cord
infection among newborns of southern Nepal. American
Journal of Epidemiology 2007;165(2):203–11.
Mullany 2009
Mullany LC, Darmstadt GL, Katz J, Khatry SK, Leclerq SC,
Adhikari RK, et al.Risk of mortality subsequent to umbilical
cord infection among newborns of southern Nepal: cord
infection and mortality. Pediatric Infectious Disease Journal
2009;28(1):17–20.
Mullany 2012
Mullany LC, Saha SK, Shah R, Islam MS, Rahman
M, Islam M, et al.chlorhexidine cord cleansing on the
bacteriologic profile of the newborn umbilical stump in
rural Sylhet District, Bangladesh: a community-based,
cluster-randomized trial. Pediatric Infectious Disease Journal
2012;31(5):444–50.
24Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Novack 1988
Novack AH, Mueller B, Ochs H. Umbilical separation
in the normal newborn. American Journal of Diseases of
Children 1988;142(2):220–3.
Oudesluys-Murphy 1987
Oudesluys-Murphy AM, Eilers GA, de Groot CJ. The time
of separation of the umbilical cord. European Journal of
Pediatrics 1987;146(4):387–9.
Oudesluys-Murphy 1990
Oudesluys-Murphy AM, den Hollander JC. Separation of
the umbilical cord--histological findings. Biology of the
Neonate 1990;58(1):54–6.
RevMan 2011
The Nordic Cochrane Centre, The Cochrane Collaboration.
Review Manager (RevMan). 5.1. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2011.
Sawardekar 2004
Sawardekar KP. Changing spectrum of neonatal omphalitis.
Pediatric Infectious Disease Journal 2004;23(1):22–6.
Sawin 1994
Sawin RS, Schaller RT, Tapper D, Morgan A, Cahill J. Early
recognition of neonatal abdominal wall necrotizing fasciitis.
American Journal of Surgery 1994;167(5):481–4.
Smith 2009
Smith CK. Some traditional umbilical cord care practices in
developing countries. Midwifery Today With International
Midwife 2009;91:12–3.
Thaver 2009
Thaver D, Zaidi AK. Burden of neonatal infections
in developing countries: a review of evidence from
community-based studies. Pediatric Infectious Disease
Journal 2009;28(1 Suppl):S3–S9.
WHO 1999
World Health Organization. Care of the umbilical cord: a
review of the evidence. WHO, maternal and newborn health
safe motherhood. Geneva: WHO, 1999.
WHO 2006
World Health Organization. Neonatal and perinatal
mortality: country, regional and global estimates. Geneva:
WHO, 2006:47.
WHO 2011
World Health Organization. Essential Medicines List 2011.
WHO (http://www.who.int/selection˙medicines/list/en/
index.html) (accessed 2011) 2011.
References to other published versions of this review
Zupan 2004
Zupan J, Garner P, Omari AAA. Topical umbilical cord care
at birth. Cochrane Database of Systematic Reviews 2004,
Issue 3. [DOI: 10.1002/14651858.CD001057.pub2]∗ Indicates the major publication for the study
25Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahmadpour-Kacho 2006
Methods Randomized, non-blinded, conducted in hospital settings.
Participants Infants 36-42 weeks, appropriate for gestational age, no disease/congenital anomalies,
mother without significant complication (N = 312)
Interventions (1) Dry care (n = 78).
(2) Breastmilk (n = 79).
(3) 95% ethyl alcohol (n = 78).
(4) Silver sulphadiazine (n = 77).
Outcomes Time to cord separation.
Notes Preterm and term.
Non-low birthweight.
Hospital setting.
Eastern Mediterranean (Iran).
All fed with own mother’s milk.
All roomed in.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not mentioned.
Allocation concealment (selection bias) Unclear risk Method not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not feasible.
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT analysis. Outcome of 61 (19.6%)
neonates (16 in dry care, 15 in breastmilk,
15 in alcohol, 15 in silver sulphadiazine)
were excluded because of concurrent use of
2 topical agents for cord care, the need for
admission in the neonatal ward for treat-
ment with antibiotics and for not reporting
time/date of cord separation
Selective reporting (reporting bias) Low risk Outcomes were reported as mentioned in
the method’s section.
26Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ahmadpour-Kacho 2006 (Continued)
Other bias High risk Baseline characteristics showed more ce-
sarean deliveries in the dry care, alcohol and
silver groups compared with the breastmilk
group
Al-Binali 2006
Methods Randomized study conducted in Saudi Arbia in hospital setting
Participants Healthy newborn admitted to nursery. Total sample size was 76 in which there were 38
babies in the alcohol group and 38 in Beniktol spray group
Interventions 1) 70% alcohol.
2) Beniktol spray (Nebacetin with Neomycin sulphate and Bacitracin)
Outcomes Cord separation time, omphalitis.
Notes No particular definition was used for omphalitis. Gestational ages of the newborns were
not mentioned in the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Comment, “Sequence generation was
based on month of delivery”
Allocation concealment (selection bias) Unclear risk Method not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Method not mentioned.
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition and exclusion were not described.
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias High risk Baseline characteristics were not compared
at the baseline.
27Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Arad 1981
Methods Randomized but method not mentioned, conducted in hospital settings at Jerusalem
Participants Healthy, appropriate-for-gestational age, term infants admitted to nursery. Total sample
size 121
Interventions Initial bath.
Daily application during hospital stay.
1. Triple dye (n = 36).
2. Neomycin ointment (n = 26).
3. Sulphadiazine ointment (n = 25).
4. Bismuth powder (n = 34).
Daily alcohol applied at home.
Outcomes Cord separation time, sepsis.
Notes No control group with dry cord care.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “..... were each randomly assigned to one
of four treatment regimens.”
Comment: Probably not done.
Allocation concealment (selection bias) Unclear risk Not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not mentioned.
Incomplete outcome data (attrition bias)
All outcomes
High risk No account of attrition or exclusion was
given in the text or tables
Selective reporting (reporting bias) Unclear risk Insufficent information to permit a judge-
ment.
Other bias High risk Bacteriological data were not obtained.
Arifeen 2012
Methods Cluster-randomized trial conducted in community settings in Bangladesh
Participants Neonates whose parents were enrolled in study.
Babies whose parents were not enrolled in parent trial and who were first visited after 48
hours of life, were excluded. Total sample size 29, 760
28Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Arifeen 2012 (Continued)
Interventions 1. Dry care (n = 10,008).
2. 4.0% chlorhexidine single application (n = 9423).
3.4.0% chlorhexidine multiple application (n = 10329).
Outcomes Omphalitis and all-cause mortality.
Notes Single and multiple application CHX groups were combined for the analysis mortality
and omphalitis analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A random allocation sequence for
each stratum was done using a computer-
generated procedure”
Allocation concealment (selection bias) Low risk Comment: As this was a cluster-random-
ized trial allocation concealment is not an
issue
Blinding (performance bias and detection
bias)
All outcomes
High risk This study was not blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and exclusion was adequately ad-
dressed.
Selective reporting (reporting bias) Low risk Study protocol was available to make an
assessment and authors reported the out-
comes mentioned in the protocol
Other bias High risk There was no effect of multiple cleansing
with CHX on neonatal mortality. This may
be due to the fact that the study was not
powered enough to detect a significant dif-
ference in this arm, as pointed out by au-
thors
Bain 1994
Methods Randomized but method not mentioned, non-blinded, non-ITT, conducted in hospital
settings
Participants Newborn with weight > 1 kg, gestational age < 37 weeks, no umbilical lines, no abdominal
surgery (N = 102)
29Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bain 1994 (Continued)
Interventions (1) Dry care (no treatment; “cleaning only with water when necessary”) (n = 28)
(2) 0.33% Hexachlorophene + 3% zinc oxide powder (Sterzac) (n = 24)
(3) 70% isopropyl alcohol (Steret) (n = 24).
(4) 70% isopropyl alcohol (Steret) + 0.33% hexachlorophene + 3% zinc oxide powder
(Sterzac) (n = 26)
Outcomes Time to cord separation.
Notes Preterm only.
Low birthweight.
Hospital setting.
Europe (Scotland).
None roomed in.
Group 2 and 4 was excluded from the analysis as it included hexachlorophene, which is
neurotoxic
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomization method.”
Allocation concealment (selection bias) Unclear risk Not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not feasible.
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT analysis. 18 babies (17.6%) were
subsequently excluded due to the insertion
of umbilical lines or transferred back to
their mothers before completion of trial
Selective reporting (reporting bias) Low risk This study seems to report the outcomes
mentioned in the methods section
Other bias High risk Higher rate of rupture of membranes > 24
hours in dry care.
Barrett 1979
Methods Randomized study conducted in USA.
Participants Infants were assigned to the normal newborn nursery, received routine general care. Total
sample size was 300
Infants who received antibiotics or developed complications precluding their assignment
to the normal newborn nursery, or who were subsequently transferred from this nursery,
30Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Barrett 1979 (Continued)
were excluded
Interventions 1. Silver sulphadiazine, single application (n = 100).
2. Triple dye, single application (n = 100).
3. Dry cord care (n = 100).
Outcomes Colonization of periumbilical area and anterior nares at 48 hours
Notes Cultures of the periumbilical area and the anterior nares were obtained at 48 hours of
age
Gestational ages of newborns were not described in the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Cord-care regimens were assigned by a com-
puter-generated table of random numbers.”
Allocation concealment (selection bias) Unclear risk Insufficent information to permit a judge-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Laboratory personnel were not aware of the
cord-care regimen the subjects had received.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk A complete account of attrition and exclusion
was given in the result’s section
Selective reporting (reporting bias) Low risk The study reported the outcomes mentioned
in the methods section
Other bias Low risk No other form of bias was found.
Davila 2007
Methods Randomized but method not mentioned (unclear), non-blinded, non-ITT, conducted
in hospital settings
Participants Healthy newborns, birthweight > 2000 g and < 4000 g, gestational age 34-41 weeks,
Apgar > or equal to 7, vaginal or abdominal delivery (N = 162)
Interventions (1) 70% alcohol (n = 57).
(2) 5% povidone iodine (n = 55).
(3) 4% chlorhexidine (n = 50).
Outcomes Time to cord separation, bacterial colonization.
31Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Davila 2007 (Continued)
Notes Preterm and term.
Low birthweight and non-low birthweight.
Latin Americas (Peru).
Paper in Spanish.
Unable to include data on time to cord separation as no SDs were reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not mentioned.
Allocation concealment (selection bias) Unclear risk Method not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
High risk Method not mentioned, blinding not fea-
sible.
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT analysis. Some mothers refused for
samples to be taken because they were dis-
charged outside of hospital hours
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias Unclear risk No table of baseline characteristics.
Dore 1998
Methods Randomized, non-blinded, non-ITT, conducted in hospital settings
Participants Admitted at postpartum unit, > or equal to 36 weeks’ gestation, not receiving antibiotics,
fewer than 8 hours of age at randomizations, spent no time in NICU, mother spoke and
read English, mother had telephone, mother planned to keep newborn (N = 1811)
Interventions (1) Dry care; “natural drying” (n = 909).
(2) 70% isopropyl alcohol (n = 902).
Outcomes Omphalitis; time to cord separation.
Notes Term.
Non-low birthweight.
Hospital setting.
Americas (Canada).
Sponge bath 52.9% vs 52.8%, tub bath 44% vs 44%.
Intention to breastfeed 87% vs 86.4%.
All roomed in (“admitted to postpartum unit”).
32Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dore 1998 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers.
Allocation concealment (selection bias) Low risk Opaque envelopes.
Blinding (performance bias and detection
bias)
All outcomes
High risk “A coloured dot for the newborn’s
bassinette indicates group assignment.”
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT analysis. 65 newborns (3.6%) did
not complete the study (27 were admit-
ted to the NICU, 25 families could not be
reached for telephone interview, 7 families
changed their mind, 6 gave mixed reason
for not participating)
Selective reporting (reporting bias) Low risk Study reported all the outcomes mentioned
in the methods section
Other bias Low risk Baseline characteristics comparable.
Evens 2004
Methods Randomized, non-blinded, non-ITT, conducted in hospital settings
Participants Infants < 34 weeks, no umbilical vessel catheterization, no umbilical cord anomalies (N
= 103)
Interventions (1) Dry care, “natural drying” (n = 50).
(2) 70% isopropyl alcohol (n = 53).
Outcomes Omphalitis; cord separation time; bacterial colonization.
Notes Preterm.
Low birthweight.
Hospital setting.
Americas (USA).
Initial bath at > 12 hours of life.
None roomed in.
Risk of bias
Bias Authors’ judgement Support for judgement
33Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Evens 2004 (Continued)
Random sequence generation (selection
bias)
Unclear risk Insufficent information to make an assess-
ment.
Allocation concealment (selection bias) Unclear risk Insufficent information to make an assess-
ment.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not feasible.
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT analysis. 7 infants (6.4%) were ex-
cluded from the final analyses because of
incomplete data due to transfer or need
for umbilical vessel catheterization. (It was
mentioned from which group were the ex-
cluded.)
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias High risk Higher rate of cesarean delivery in alcohol
group (83% vs 69%)
Gladstone 1988
Methods Randomized study conducted in hospital settings in USA.
Participants Inborn healthy term infants > 2500 g. A total of 249 participants were included (53, 48,
44, 42, 14, and 48 in each group)
Interventions 6 study groups
1. Triple dye once daily until separation.
2. Triple dye once then alcohol until separation.
3. Triple dye once only.
4. Povidone iodine daily until separation.
5. Silver sulphadiazine daily until separation.
6. Bacitracin ointment until cord separation.
Outcomes Colonization at discharge from hospital.
Separation time.
Maternal satisfaction.
Local or other infections.
Nursing staff satisfaction.
Notes Infants were excluded from the study for any of the following reasons: birthweight less
than 2500 g, gestational age less than 37 weeks, refusal to give consent, non-routine
treatments such as phototherapy or systemic antibiotics, or follow-up care planned at a
different medical facility
34Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gladstone 1988 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “by use of a table of random num-
bers”.
Allocation concealment (selection bias) Unclear risk Insufficent information to make an assess-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to make an assess-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and excluded participants were
adequately described in the result’s section
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias Low risk Baseline characteristics comparable.
Golombek 2002
Methods Randomized trial conducted in hospital settings in USA.
Participants Infants admitted to the well-baby nursery. A total of 634 infants were enrolled and 599
completed the study
Interventions 1. Alcohol (n = 292).
2. Triple dye (n = 342).
Outcomes Cord infection.
Cord separation.
Nursing staff satisfaction.
Notes Data for cord separation time were not included as means and SDs were not given
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Comment: Triple dye was applied to in-
fants admitted to newborn nursery during
month of January and March while alcohol
was applied during months of December
and February
35Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Golombek 2002 (Continued)
Allocation concealment (selection bias) High risk Comment: Methods of randomizations
were not adequate and no effort was made
to conceal the allocation
Blinding (performance bias and detection
bias)
All outcomes
High risk Comment: Intervention was known to
house staff, parents and assessors
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and exclusion was adequately de-
scribed in the result’s section
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias High risk Data on incidence of omphalitis were gath-
ered by telephone calls. No home visits were
made to make an assessment
Hsu 1999
Methods A randomized study conducted in hospital settings in Taiwan.
Participants Healthy term newborn, 101 in experimental group and 79 in control group
Interventions 1. Triple dye, single application.
2. Triple dye, daily application.
Single application group was later treated with 70% alcohol until discharge from hospital
while the second group was continued to be treated with triple dye
Outcomes Cord separation time.
Omphalitis.
Notes Daily whole body wash with soap for both the groups.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization methods were not de-
scribed.
Allocation concealment (selection bias) Unclear risk Randomization methods were not de-
scribed.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information was provided about blind-
ing.
36Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hsu 1999 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Exclusion and attrition was described.
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias Unclear risk Single application group was treated with
another antiseptic(i.e. 70% alcohol) that
may interfere with cord separation time
Hsu 2010
Methods Randomized trial.
Participants Newborn delivered at Tri-Service Heneral Hospital, Taiwan. Total sample size 142
Interventions 1) Dry cord care (n = 71).
2) 95% isopropyl alcohol (n = 71).
Outcomes Cord separation time
Notes Following newborns were excluded:
1) low birthweight < 2500 g;
2) gestational age < 36 weeks;
3) those receiving phototherapy;
4) being treated with systemic antibiotics;
5) those with umbilical catheters;
6) diagnosed with any disease before discharge;
7) who transgressed study protocols;
8) or were lost to follow-up.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “They were then randomly assigned to one of two groups for
cord management”. No more details were provided for sequence
generation
Allocation concealment (selection bias) Unclear risk Insufficent information to make an assessment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to make an assessment.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Reason for exclusion and attrition were given.
37Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hsu 2010 (Continued)
Selective reporting (reporting bias) Low risk Study reported all the outcomes mentioned in the methods sec-
tion
Other bias Unclear risk None noticed.
Huang 2001
Methods “Randomly assigned” but method not mentioned (unclear), open label, non-ITT, con-
ducted in hospital settings
Participants Healthy term newborns (N = 150).
Interventions (1) Dry care (n = 75).
(2) 95% alcohol (n = 75).
Outcomes Omphalitis and umbilical cord separation time.
Notes Term.
Non-low birthweight.
Hospital setting.
Western Pacific (Taiwan).
Daily bath with ordinary soap.
None roomed in.
Only abstract available for evaluation.
No data were included as the means and SDs were not given.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not mentioned.
Allocation concealment (selection bias) Unclear risk Method not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not mentioned; not feasible.
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT. 8 neonates (5.3%) were excluded:
dry care (3 protocol breach and 1 lost to
follow-up) and alcohol (4 lost to follow-up)
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias Low risk Comparable baseline characteristics.
38Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Janssen 2003
Methods Randomized, non-blinded, ITT conducted in hospital settings.
Participants Hospital born, no antibiotics since birth, Vancouver address, fluent in English, Can-
tonese or Mandarin, not admitted to level III nursery (N = 766)
Interventions (1) Dry care (n = 382).
(2) Triple dye on day of birth then alcohol until cord separation (n = 384)
Outcomes Omphalitis; bacterial colonization.
Notes No mention of gestational age or birthweight.
Hospital setting with community follow-up.
Americas (Canada).
Daily bath with mild soap.
Breastfeeding at discharge 95% vs 95.6%.
Exclusive breastfeeding at home visit 69.9% vs 72.4%.
Mixed feeding at home visit 24.9% vs 24.2%.
“Omphalitis was defined as erythema (redness, swelling and/or warmth) of the abdominal
skin in the periumbilical region, extending beyond 5mm from the umbilicus.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomization was stratified on the clin-
ical area; consecutively numbered opaque
envelopes
Allocation concealment (selection bias) Low risk Sealed opaque envelopes.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not mentioned; not feasible.
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis.
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias Low risk Baseline characteristics comparable.
39Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kapellen 2009
Methods Randomized, non-blinded, non-ITT, conducted in hospital settings
Participants Healthy newborn within the 1st 36 hours of life, 37-42 weeks’ gestation, birthweight >
2500 g, with consent (N = 669)
Interventions (1) Dry care (n = 332).
(2) Chlorhexidine powder (n = 337).
Outcomes Omphalitis, time to cord separation.
Notes Term.
Non-low birthweight.
Hospital setting.
Europe (Germany).
Admitted to nursery then roomed in.
Omphalitis was defined the classification of (Mason 1989).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomized by sealed envelope, random-
izations was stratified in neonates delivered
normally or by caesarean section because
of the expected differences in time to cord
detachment
Allocation concealment (selection bias) Low risk Sealed envelope.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not mentioned; not feasible.
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT analysis. 669 neonates were en-
rolled but cord separation time was only
documented in 578 neonates (13.6% miss-
ing); no mention of breakdown of dropouts
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias Low risk “Neonates randomized to either group did
not differ in sex, ethnicity, birthweight or
length, gestational age, mode of delivery or
Apgar score.” (No table of baseline charac-
teristics.)
40Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Meberg 1985
Methods Hospital-based randomized study conducted in Norway.
Participants Healthy term newborn admitted to nursery. A total of 547 infants were included
Interventions 1. Benzine daily (n = 113).
2. Chlorhexidine (0.05%) daily (n = 217).
3. Total body wash with soap (n = 217).
Outcomes Colonization of stump at discharge.
Infection (umbilical and severe) within 6 weeks.
Notes Phase 1: 1982; Phase 2: 1983.
Roomed in with mothers.
Data were give for all kind of infection (pemphigus, conjunctivitis, paronychia, and
umbilical infection) and no separate data were available for omphalitis (cord infection)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “infants were consecutively and
randomly selected to 1 of the following
groups”. There was no description of exact
methods of sequence generation
Allocation concealment (selection bias) Unclear risk Insufficent information to permit a judge-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit a judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and exclusion were adequately de-
scribed in result’s section
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias High risk No description of baseline characteristics of
study participants was given
Meberg 1990
Methods Prospective randomized study conducted in hospital setting in Norway
Participants Healthy term infants admitted to newborn nursery. A total of 2441 infants were registered
41Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Meberg 1990 (Continued)
Interventions 1. Hydrophobic gauze material bandage, applied daily (n = 1213).
2. Chlorhexidine in alcohol, applied daily (n = 1228).
Outcomes Infections of skin, cord, eyes during stay and at 6 weeks.
Cord separation time.
Notes Methods of statistical analyses were not described in adequate details
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Births were consecutively num-
bered, and infants with even and uneven
numbers enlisted into the two groups re-
spectively.”
Allocation concealment (selection bias) Unclear risk Insufficent information to permit a judge-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit a judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and exclusion were adequately de-
scribed in results section
Selective reporting (reporting bias) Unclear risk Insufficent information to permit a judge-
ment.
Other bias High risk No description of baseline characteristics of
study participants were given
Medves 1997
Methods Randomized, non-blinded, ITT, conducted in hospital settings
Participants Term infants (except 1 born 36 weeks and 5 days), born at a tertiary care hospital in
Western Canada (N = 148)
Interventions (1) Alcohol (n = 74).
(2) Sterile water (n = 74).
Outcomes Bacterial colonization; time to cord separation.
Notes Preterm (1 participant), term.
No mention of birthweight.
Hospital setting.
42Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Medves 1997 (Continued)
Americas (Canada).
Initial bath with chlorhexidine gluconate 2% within first 6 hours of life
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Blocked randomizations.
Allocation concealment (selection bias) Unclear risk Not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
Low risk Only outcome assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis for bacterial colonization. “In-
fants remained in the treatment group to
which they were assigned, even if the par-
ents did not follow the treatment”
Selective reporting (reporting bias) Low risk Study reported the outcomes mentioned in
the method’s section
Other bias Unclear risk No table of baseline characteristics.
Mugford 1986
Methods Randomized, blinded, non-ITT, conducted in hospital settings
Participants Babies born in the labour ward, normal postnatal care, singleton, mother resident of
West Berkshire District. (N = 815)
Interventions It was a factorial design trial that compared different forms of antiseptics, cleansing
method and frequency of application. The trial studied powders (zinc and baby talcum
powder = 203, Sterzac = 204, Cordocel = 202, no powder = 203), Cleansing method
(water = 272, spirit = 271, and no routine cleansing = 272) and frequency of application
(daily = 407 and once only = 408)
Outcomes Time to cord separation.
Notes Hospital setting.
Europe (England).
All rooming in (“admitted to postnatal ward”).
There was no mention of gestational age or birthweight of the babies
Data for group 5 and 6 were excluded.
Risk of bias
43Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mugford 1986 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomized”. Method not mentioned.
Allocation concealment (selection bias) Low risk Sealed envelope. Use of “blind” packaging
so that it was not possible to guess the al-
location before entry of a baby to the trial
Blinding (performance bias and detection
bias)
All outcomes
High risk Not feasible.
Incomplete outcome data (attrition bias)
All outcomes
High risk No ITT analysis.
Selective reporting (reporting bias) Low risk Study reported the outcomes mentioned in
the method’s section
Other bias Low risk “Groups are comparable in respect in dis-
tributions of sex, birthweight and mode of
delivery.” Cannot extrapolate data from in-
cluded table of results
Mullany 2006
Methods Cluster-randomized, double-blind (for chlorhexidine and soap and water), study con-
ducted in community settings
Participants All infants born after November 17, 2002, in 413 actively monitored enters in Southern
Nepal, with consent, alive at first visit, first visit within first 10 days of life
Interventions (1) Dry care (n = 5082).
(2) 4% chlorhexidine (n = 4924).
(3) Soap and water (n = 5107).
Outcomes Time to cord separation; neonatal mortality and omphalitis.
Notes No mention of gestational age.
Low birthweight and non-low birthweight.
Community-based.
South-East Asia (Nepal).
Initial cleansing full body wipe with 0.25% chlorhexidine or placebo
No breastfeeding < 1% all groups.
Breastfeeding initiated at < 11.9 hours 46% vs 52% vs 47%.
Facility birth 8% vs 8% vs 9%.
Data on omphalitis have been taken from table 3 for the category of “moderate or sever
redness”
44Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mullany 2006 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random sequence.
Allocation concealment (selection bias) Unclear risk Method not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Investigators, field workers, and partic-
ipants were masked with respect to the
chlorhexidine and soap/water treatment
groups”. Not blinded to dry care
Incomplete outcome data (attrition bias)
All outcomes
Low risk No ITT analysis. A total of 15,113 infants
were enrolled in the trial but analyses were
restricted to 14,887 (98.4%) of those in-
fants, for whom specific information on
time to cord separation was collected (1.
5% missing)
Selective reporting (reporting bias) Low risk This study appears to be free of selective re-
porting. Outcomes are described in 2 dif-
ferent papers
Other bias Low risk Comparable baseline characteristics.
Nourian 2009
Methods A quasi-randomized study conducted in Iran.
Participants Healthy term Newborn, 36 in group 1 and 41 in group 2.
Interventions 1) Dry cord care.
2) 70 alcohol.
Outcomes Omphalitis.
Bacterial colonization.
Cord separation time.
Notes Hospital-based study
Newborns with gestational age < 37 weeks, birthweight < 2500 g, Apgar score < 8 and
the twins were excluded and so were infants receiving antibiotics or developing any
complications requiring hospitalization
SDs for mean cord separation time were not given in the study. They were derived from
other studies with similar settings and sample size
Omphalitis data were taken from table 2. Redness, exudates, foul odor, tenderness and
45Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nourian 2009 (Continued)
inflammation were taken as signs of omphalitis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk A quasi-randomized study.
Allocation concealment (selection bias) High risk A quasi-randomized study.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding methods were not described in the
study.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition was described in the results sec-
tion.
Selective reporting (reporting bias) Low risk Study reports all the outcomes mentioned
in the method’s section
Other bias Low risk None noticed.
Oishi 2004
Methods Randomized, double-blind, no ITT, conducted in hospital settings
Participants Neonates born at National Tokyo Medical Centre from March to May 2000, nursed at
a maternity ward from birth to discharge, with consent (N = 100)
Interventions (1) 80% ethanol (n = 52).
(2) 80% ethanol with 0.5% chlorhexidine (n = 48).
Outcomes Omphalitis, bacterial colonization.
Notes Preterm, term.
Low birthweight, non-low birthweight.
Hospital setting.
Western Pacific (Japan).
Daily bath.
All roomed in (“admitted to maternity ward from birth”).
Reports omphalitis but does not state which group.
Risk of bias
Bias Authors’ judgement Support for judgement
46Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Oishi 2004 (Continued)
Random sequence generation (selection
bias)
Low risk Table of random numbers.
Allocation concealment (selection bias) Unclear risk Method not mentioned.
Blinding (performance bias and detection
bias)
All outcomes
Low risk The mothers of the neonates and the nurs-
ing staff were unaware as to which disinfec-
tant was being used
Incomplete outcome data (attrition bias)
All outcomes
High risk For colonization, complete outcomes re-
ported for all participants for omphalitis,
no ITT analysis. 1 case of omphalitis but
not stated in which group; no loss of par-
ticipants
Selective reporting (reporting bias) Unclear risk Insufficent information to make an assess-
ment.
Other bias High risk Alcohol group had low birthweight babies
but the proportion is not specified
Panyavudhikrai 2002
Methods Randomized trial, conducted in hospital settings.
Participants Neonates born at department of obstetrics and gynaecology, Siriraj hospital, Thialand.
Mean gestational age of included babies was 38 weeks. Total n = 272
Interventions 1) Povidine-iodine (n = 93).
2) Triple dye (n = 90).
3) 70% alcohol (n = 89).
Outcomes Incidence of omphalitis, cord separation time.
Notes Data have been included for 70% alcohol vs triple dye only, as the data for Povidine
group were incomplete
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Simple randomisation was used”, No fur-
ther description of the sequence generation
procedure was described
Allocation concealment (selection bias) Unclear risk Insufficent information to permit judge-
ment.
47Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Panyavudhikrai 2002 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment.
Other bias Unclear risk Insufficent information to permit judge-
ment.
Perapoch 1993
Methods Randomized study conducted in hospital settings in Spain.
Participants Healthy term newborns admitted to nursery. A total of 311 infants were included in the
study
Interventions 1. Alcohol (70%) (n = 75).
2. Alcohol + mercurochrome (n = 78).
3. Mercurochrome (n = 84).
4. Chlorhexidine (1%) (n = 74).
Outcomes Cord infection.
Cord separation.
Bacterial colonization.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “They were randomly assigned to
one of the four assessed methods”. No fur-
ther details of methods of randomization
were given
Allocation concealment (selection bias) Unclear risk Insufficent information to permit judge-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
48Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Perapoch 1993 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk No details of exclusion or attrition were
given.
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment.
Other bias High risk Baseline characteristics of study partici-
pants were not given
Pezzati 2002
Methods Randomized study conducted in hospital settings
Participants Healthy term newborns admitted to nursery. A total of 1470 infants were included
Interventions 1. Salicylic sugar powder (n = 167).
2. Green clay powder (n = 184).
3. Natural drying (n = 177).
4. Katoxin (n = 208).
5. Cicatrene (n = 174).
6. 1% basic fuschine (n = 187).
7. Triple dye (n = 195).
8. 70% alcohol (n = 178).
Outcomes Sepsis.
Death.
Cord infection.
Cord separation.
Cord bleeding.
Compliance.
Parental satisfaction.
Bacterial colonization.
Notes Preterm (gestational age < 37 weeks) and low birthweight (< 2500 g) infants were excluded
from the study, as well as infants who were receiving phototherapy, antibiotics or who
developed complications of any kind requiring hospitalization in our neonatal pathology
unit
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: ”It was deemed unnecessary to
make use of a stricter randomization since
the type of treatment was recognizable both
by the nursery staff and parents.”
49Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pezzati 2002 (Continued)
Allocation concealment (selection bias) High risk Quote: ”It was deemed unnecessary to
make use of a stricter randomization since
the type of treatment was recognizable both
by the nursery staff and parents.“
Blinding (performance bias and detection
bias)
All outcomes
High risk Quote: ”It was deemed unnecessary to
make use of a stricter randomization since
the type of treatment was recognizable both
by the nursery staff and parents.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and exclusion were adequately de-
scribed in result’s section
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment.
Other bias Low risk Baseline characteristics were comparable at
the baseline.
Pezzati 2003
Methods A prospective randomized trial conducted in Italy in hospital settings
Participants Premature neonates. Total sample size was 213.
Interventions 1) 4% Cchlorhexidine solution (n = 101).
2) Salicylic sugar powder (n = 112).
Outcomes Mortality.
Sepsis.
Cord separation time.
Bacterial colonization.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “A prospective, randomised study
was conducted on all premature infants”
Exact methods of sequence generation were
not described.
Allocation concealment (selection bias) Low risk Quote: “The patients were selected to enter
either of the 2 groups randomly by means
of the sealed envelope technique”
50Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pezzati 2003 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Quote: “The caregivers were not blinded
as to allocation because the cord stumps
looked different depending on which treat-
ment group the infant was in”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Exlusion and attrition was described in the
result section.
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment.
Other bias Unclear risk None noticed.
Rosenfeld 1989
Methods Randomized study conducted in hospital settings in USA.
Participants Premature babies < 2200 g. A total of 114 babies were included in the study
Interventions 1. Triple dye, single application (n = 54).
2. Isopropyl alcohol each diaper change (n = 60).
Outcomes Colonization on day 4 and at discharge.
Notes Only Abstract available.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Alternate allocation.
Allocation concealment (selection bias) High risk Inadequate methods of randomization.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
High risk No details of exclusion or attrition were
given.
Selective reporting (reporting bias) Low risk Study reported the outcomes mentioned in
the methods section
Other bias Low risk Baseline characteristics were comparable
between the 2 groups
51Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rush 1986
Methods Randomized study conducted in hospital settings in Canada.
Participants Heathy term newborns admitted to nursery. A total of 181 infants were included in the
study
Interventions 1. Routine daily bath with water and soap (n = 95).
2. Initial bath only(n = 86).
Outcomes Colonization on day 4 in the nose and umbilicus.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficent information to permit judge-
ment.
Allocation concealment (selection bias) Unclear risk Insufficent information to permit judge-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Details of exclusion and attrition were ad-
equately described
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment.
Other bias Low risk Baseline characteristics were comparable
between the 2 groups
Schuman 1985
Methods Randomized trial conducted in hospital settings.
Participants Newborns delivered at USAF hospital, Grand forks, USA (N = 71)
Interventions 1) Triple dye (n = 35).
2) Isopropyle alcohol (n = 36).
Outcomes Cord separation time.
Notes The following infants were excluded from the analysis:
1) infants receiving phototherapy;
52Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Schuman 1985 (Continued)
2) had insertion of umbilical catheter;
3) during hospitalizations developed complications.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “.....infants were randomly assigned by
computer to one of two treatment regi-
mens.”
Allocation concealment (selection bias) Unclear risk Insufficent information to permit judge-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment.
Other bias Unclear risk Insufficent information to permit judge-
ment.
Shafique 2006
Methods A quasi-randomized study conducted in Pakistan.
Participants Full term newborn, 50 in group A and 50 in group B.
Interventions A) 70% alcohol.
B) Dry cord care.
Outcomes Cord separation time.
Notes Study conducted in hospital settings.
The exclusion criteria were maternal pyrexia (temperature more than 38°C) during
labour, premature rupture of membrane for greater than 18 hours, low birthweight
newborns (weight < 2.5 kg), newborns being given oral or systemic antibiotic, admission
in nursery within 48 hours after birth and presence of open congenital anomalies in the
newborn
Risk of bias
Bias Authors’ judgement Support for judgement
53Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Shafique 2006 (Continued)
Random sequence generation (selection
bias)
High risk A quasi-randomized study.
Allocation concealment (selection bias) High risk A quasi-randomized al study.
Blinding (performance bias and detection
bias)
All outcomes
High risk No methods described for blindings.
Incomplete outcome data (attrition bias)
All outcomes
High risk No reasons for loss to follow-up were de-
scribed.
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment..
Other bias High risk Data on umbilical cord infections and sep-
sis were collected by telephone and no
physician examined the child for surveil-
lance
Soofi 2012
Methods 2 x 2 cluster-randomized community trial conducted in Pakistan
Participants Newborn whose parents were enrolled in the study (N = 9741).
Interventions 1) Chlorhexidine (n = 2214).
2) Chlorhexidine + handwashing (n = 2475).
3) Handwashing alone (n = 2653).
4) Control (n = 2399).
Outcomes Omphalitis, all-cause mortality, cord separation time.
Notes Intervention was delivered by TBAs. Factorial analysis (chlorhexidine vs no chlorhexi-
dine) was included in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “.........randomly allocated to one
of four groups (groups A to D) with a
computer-generated random number se-
quence”
Allocation concealment (selection bias) Low risk Comment: As this was a cluster-random-
ized trial allocation concealment is not an
issue
54Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Soofi 2012 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Comment: Particiants were not blinded to
the intervention however, Implementation
and data collection teams were masked to
allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and exclusion were adequately de-
scribed. ITT analysis
Selective reporting (reporting bias) Low risk This study was free of selective reporting.
Other bias High risk The desired sample size was not achieved
due to security situation in the study area
Speck 1977
Methods Randomized trial conducted in hospital settings.
Participants Term healthy newborn. A total of 240 newborn babies were included in the study
Interventions 1. Daily wash with Castile soap (n = 78).
2. Triple dye (n = 80).
3. Silver sulphadiazine (n = 82).
Routine daily sponge bath with tap water.
After discharge, daily application of isopropanol.
Outcomes Bacterial culture from the nose day 3, 14.
Cord infection. Conjunctivitis. Impetigo.
Notes Data were taken from table II. Percentages were converted into number of events
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficent information to permit judge-
ment.
Allocation concealment (selection bias) Unclear risk Insufficent information to permit judge-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficent information to permit judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and exclusion were described in
the results section
55Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Speck 1977 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficent information to permit judge-
ment.
Other bias High risk Baseline characteristics of study partici-
pants were not given
Suliman 2010
Methods A prospective, randomized clinical trial conducted in US in hospital settings
Participants Healthy full term newborn, 90 babies completed the study.
Interventions 1) Alcohol rub plus triple dye application (n = 46).
2) Triple dye application alone (n = 44).
Outcomes Omphalitis.
Cord separation time.
Notes Data were described for different appearances of cord but no definition was used to
define omphalitis
SDs were not given for cord separation time. We used the SDs from similar settings with
similar sample size
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “.......newborns were randomised to
receive either no further preventive treat-
ment to their umbilical cord or twice daily
rubbing alcohol application”
Allocation concealment (selection bias) Unclear risk Insufficent information to make an assess-
ment.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Methods of blinding were not described.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition and exclusion was described.
Selective reporting (reporting bias) Low risk Study reported all the outcomes mentioned
in the method’s section
Other bias Unclear risk No physical surveillance was done to make
an assessment for cord infection
56Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
CHX: chlorhexidine
ITT: Intention-to-treat (analysis)
NICU: neonatal intensive care unit
SD: standard deviation
TBAs: traditional birth attendants
vs: versus
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alda 2000 Comparison between hexachlorophene and chlorhexidine. Hexachlorophene not recommended anymore
because of central nervous toxicity
Aldar 1980 Comparison between hexachlorophene, which is not recommended anymore due to neural toxicity, and
chlorhexidine
Barclay 1994 This study is not a randomized trial. 890 babies in comparison between chlorhexidine and no specific
treatment to cord
Bhakoo 1969 Non-randomized, no alcohol or dry care in treatment, comparison between bathing and non-bathing
Birenbaum 1990 Not cord care.
Bourke 1989 This study was not a randomized trial. All babies born in 2 designated wards were entered into study. The
treatment groups included dry cord care and alcohol (70%)
Bradshaw 1993 Independent effect of alcohol cannot be assessed; alcohol was administered with hexachlorophene powder.
Hexachlorophene not recommended anymore because of central nervous toxicity
Chamnanvanakij 2005 Triple dye applied to all participants before randomization.
Coyer 1975 Not cord care.
Darmstadt 2007 Not cord care.
Erenel 2010 A quasi-experimental study.
Gezon 1964 Not cord care.
Gluck 1963 Non-randomized, total body skin care including cord.
Guala 2003 6 study groups. Allocation was in groups of 50. No randomization was done
Guinsburg 1991 4 study groups. Only abstract available. Non-randomized.
Healey 1991 Not cord care.
57Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Henningsson 1981 Not cord care.
Hnatko 1977 Intervention included hexachlorophene which is not recommended because of central nervous toxicity.
Allocation to groups was according to predetermined schedule
Hodgins 2010 No dry cord care group, comparison between gel and aqueous chlorhexidine
Jellard 1957 All received surgical spirit so effect of treatment with antiseptics could not be assessed
Kumar 2008 Not cord care.
Kwong 1973 Non-randomized, total body bathing.
Olowe 1980 Not cord care.
Pildes 1973 Non-randomized, no alcohol or dry care in treatment.
Pyati 1977 Controlled trial in which multiple applications of povidone iodine were compared with a single application
Ronchera-Oms 1994 Non-randomized.
Saleem 2007 Not cord care.
Saleem 2010 Not a cord care study.
Shah 2010 Not a cord care study.
Smales 1988 No alcohol or dry care in treatment. 2 hospitals with different regimens reversed after 2 months
Tielsch 2006 Not cord care.
Tielsch 2007 Not cord care.
Wade 2006 Not cord care.
Wald 1977 1 of the treatment arms used Hexachlorophene which is not recommended because of central nervous
toxicity
Watkinson 1992 Comparison between alcohol and hexachlorophane with no antiseptic. Hexachlorophene not recommended
because of central nervous toxicity
Wojciechowska 1989 Study completed but not analyzed. No data available.
58Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Characteristics of studies awaiting assessment [ordered by study ID]
Covas 2011
Methods Open prospective controlled clinical trial.
Participants Newborns.
Interventions Study group-body bath with neutral soap in the first 2 days of life and natural drying of the umbilical cord without
special treatment
Control group -umbilical cord hygiene with alcohol 70% at each diaper change until its separation and bath 2 days
later
Outcomes Cord separation time.
Notes Need full text for further assessment.
Nasrallah 2003
Methods Randomized trial.
Participants Newborn.
Interventions Intervention: 70% isopropyl alcohol application.
Control: natural drying of the cord.
Outcomes Cord separation time.
Notes Need full text for further assessment.
Sellares Casas 2002
Methods Experimental study.
Participants Newborn, total sample size 285.
Interventions 1) 1 application of Merbromin.
2) 3 application of Merbromin.
Outcomes Omphalitis.
Cord separation time.
Notes Need full text for further assessment.
59Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Srinivasan 2003
Methods Randomized trial.
Participants Very low birthweight infants admitted to Mount Sinai hospital
Interventions Intervention: umbilical cord cleaned with alcohol swab, followed by application of triple dye daily
Control: umbilical cord cleaned with alcohol swab.
Outcomes Bacterial colonization.
Notes Need full text for further assessment.
Taffazoli 2008
Methods Randomized clinical trial conducted in Iran.
Participants Newborn, total sample size 118.
Interventions 1) Mothers milk.
2) Dry cord care.
Outcomes Cord separation time.
Bacterial colonization.
Notes Need full text for further assessment.
Characteristics of ongoing studies [ordered by study ID]
Hamer 2010
Trial name or title Zambia Chlorhexidine Application Trial (ZamCAT).
Methods Cluster-randomized community trial.
Participants Newborn whose parents are enrolled in the study.
Interventions Chlorhexidine cord care: experimental.
Control group: dry cord care.
Outcomes All-cause neonatal mortality and neonatal omphalitis.
Starting date November 12 2010.
Contact information Principal Investigator: Davidson H Hamer, MD: Boston University Center for Global Health and Develop-
ment
Notes Currently the trial is in recruitment phase.
60Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sazawal 2012
Trial name or title Chlorhexidine Cordcare for Reduction in Neonatal Mortality and Omphalitis (CHX-Pemba)
Methods Community-based controlled trial.
Participants Inclusion criteria
• Permanent resident of Pemba.
• Consenting to participate, infants alive at first contact with MCH/TBA/Hospital staff.
• First contact within 48 hours of delivery.
Exclusion criteria
• Congenital malformations where application of intervention is not possible.
• Very sick child needing hospitalization and ICU care.
Interventions 1. Experimental: 4% chlorhexidine cord application for 10 days
2. Active comparator: control: same liquid as intervention without the chlorhexidine used for cord cleaning
for 10 days once daily
3. No intervention: dry cord care use current recommended keep cord dry
Outcomes Neonatal mortality.
Omphalitis.
Starting date October 2010.
Contact information Contact: Said M Ali, MS.
Notes
ICU: intensive care unit
61Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Antispetics vs dry cord care/placebo. Studies conducted in community settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality 3 Risk Ratio (Random, 95% CI) Subtotals only
1.1 Chlorhexidine versus dry
cord care/placebo
3 Risk Ratio (Random, 95% CI) 0.77 [0.63, 0.94]
2 Omphalitis: Algorithm 1:
Redness extending to skin
3 Risk Ratio (Random, 95% CI) 0.73 [0.64, 0.83]
3 Omphalitis: Algorithm 2:
Redness with pus or severe
redness
3 Risk Ratio (Random, 95% CI) 0.69 [0.60, 0.79]
4 Omphalitis: Algorithm 3: severe
redness with pus
3 Risk Ratio (Random, 95% CI) 0.44 [0.28, 0.69]
5 Bacterial colonization:
Staphyococcus aureus1 5234 Risk Ratio (M-H, Random, 95% CI) 0.27 [0.23, 0.31]
6 Bacterial colonization: E.coli 1 5234 Risk Ratio (M-H, Random, 95% CI) 0.50 [0.46, 0.54]
7 Bacterial colonization:
Streptococcus
1 5234 Risk Ratio (M-H, Random, 95% CI) 0.28 [0.22, 0.37]
8 Cord separation time (days) 2 37233 Mean Difference (IV, Random, 95% CI) 1.75 [0.44, 3.05]
8.1 Chlorhexidine 2 37233 Mean Difference (IV, Random, 95% CI) 1.75 [0.44, 3.05]
Comparison 2. Antiseptics vs dry cord care/placebo. Studies conducted in hospital settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 Omphalitis 5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Alcohol 3 484 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.62, 1.39]
1.2 Triple dye 2 968 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.13, 3.73]
1.3 Chlorhexidine 1 669 Risk Ratio (M-H, Random, 95% CI) 0.28 [0.06, 1.35]
1.4 Salicylic sugar powder 1 344 Risk Ratio (M-H, Random, 95% CI) 0.21 [0.01, 4.38]
1.5 Green clay powder 1 361 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.04, 5.26]
2 Bacterial colonization:
Staphylococcus aureus6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Alcohol 2 432 Risk Ratio (M-H, Random, 95% CI) 0.61 [0.11, 3.36]
2.2 Triple dye 4 1319 Risk Ratio (M-H, Random, 95% CI) 0.15 [0.10, 0.22]
2.3 Silver sulphadiazine 2 360 Risk Ratio (M-H, Random, 95% CI) 0.72 [0.60, 0.87]
2.4 Chlorhexidine 1 216 Risk Ratio (M-H, Random, 95% CI) 0.65 [0.55, 0.77]
2.5 Benzine 1 221 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.90, 1.09]
2.6 Salicyclic sugar powder 1 344 Risk Ratio (M-H, Random, 95% CI) 0.32 [0.17, 0.58]
2.7 Green clay powder 1 361 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.31, 0.82]
2.8 Katoxin powder 1 385 Risk Ratio (M-H, Random, 95% CI) 1.43 [1.02, 2.00]
2.9 Fuschine 1 364 Risk Ratio (M-H, Random, 95% CI) 0.52 [0.32, 0.84]
62Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3 Bacterial colonization:
Streptococcus
6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Alcohol 2 432 Risk Ratio (M-H, Random, 95% CI) 0.42 [0.15, 1.19]
3.2 Triple dye 3 947 Risk Ratio (M-H, Random, 95% CI) 0.57 [0.28, 1.18]
3.3 Silver sulphadiazine 2 360 Risk Ratio (M-H, Random, 95% CI) 0.62 [0.43, 0.89]
3.4 Chlorhexidine 1 216 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.27, 1.04]
3.5 Salicyclic sugar powder 1 344 Risk Ratio (M-H, Random, 95% CI) 0.74 [0.29, 1.90]
3.6 Green clay powder 1 361 Risk Ratio (M-H, Random, 95% CI) 4.62 [2.41, 8.84]
3.7 Katoxin powder 1 385 Risk Ratio (M-H, Random, 95% CI) 5.87 [3.12, 11.05]
3.8 Fuschine 1 364 Risk Ratio (M-H, Random, 95% CI) 0.19 [0.04, 0.85]
4 Bacterial colonization: E. coli 5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
4.1 Alcohol 2 432 Risk Ratio (M-H, Random, 95% CI) 0.73 [0.58, 0.92]
4.2 Triple dye 2 789 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.53, 1.17]
4.3 Silver sulphadiazine 1 200 Risk Ratio (M-H, Random, 95% CI) 0.7 [0.53, 0.93]
4.4 Chlorhexidine 1 216 Risk Ratio (M-H, Random, 95% CI) 0.59 [0.39, 0.90]
4.5 Salicyclic sugar powder 1 344 Risk Ratio (M-H, Random, 95% CI) 0.59 [0.32, 1.10]
4.6 Green clay powder 1 361 Risk Ratio (M-H, Random, 95% CI) 1.27 [0.79, 2.05]
4.7 Katoxin powder 1 385 Risk Ratio (M-H, Random, 95% CI) 1.12 [0.70, 1.81]
4.8 Fuschine 1 364 Risk Ratio (M-H, Random, 95% CI) 2.04 [1.33, 3.13]
5 Parental satisfaction 1 355 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.45, 0.66]
6 Time to cord separation (days) 11 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 Alcohol 9 2921 Mean Difference (IV, Random, 95% CI) 1.76 [0.03, 3.48]
6.2 Zinc powder 1 401 Mean Difference (IV, Random, 95% CI) -1.82 [-2.23, -1.41]
6.3 Triple dye 1 372 Mean Difference (IV, Random, 95% CI) 4.1 [3.07, 5.13]
6.4 Salicylic sugar powder 1 344 Mean Difference (IV, Random, 95% CI) -1.90 [-2.47, -1.33]
6.5 Green clay powder 1 361 Mean Difference (IV, Random, 95% CI) -0.80 [-1.36, -0.24]
6.6 Katoxin powder 1 385 Mean Difference (IV, Random, 95% CI) 0.80 [0.18, 1.42]
6.7 Fuschine 1 364 Mean Difference (IV, Random, 95% CI) 2.80 [2.01, 3.59]
6.8 Silver sulphadiazine 1 155 Mean Difference (IV, Random, 95% CI) 3.60 [2.66, 4.54]
6.9 Breastmilk 1 157 Mean Difference (IV, Random, 95% CI) -1.69 [-2.31, -1.07]
6.10 Chlorhexidine 1 669 Mean Difference (IV, Random, 95% CI) -0.80 [-1.21, -0.39]
Comparison 3. Antiseptic vs antibiotic. Studies conducted in hospital settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 Bacterial colonization:
Staphylococcus aureus1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Triple dye vs bacitracin 1 62 Risk Ratio (M-H, Random, 95% CI) 0.65 [0.03, 12.87]
1.2 Silve sulphadiazine vs
bacitracin
1 92 Risk Ratio (M-H, Random, 95% CI) 2.18 [0.42, 11.33]
1.3 Povidine vs bacitracin 1 92 Risk Ratio (M-H, Random, 95% CI) 2.18 [0.42, 11.33]
2 Time to cord separation (days) 3 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Triple dye vs bacitracin 1 62 Mean Difference (IV, Random, 95% CI) -5.60 [-9.36, -1.84]
2.2 Triple dye vs neomycin 1 62 Mean Difference (IV, Random, 95% CI) -4.3 [-6.27, -2.33]
2.3 Silve sulphadiazene vs
neomycin
1 51 Mean Difference (IV, Random, 95% CI) -1.40 [-3.65, 0.85]
2.4 Povidine vs bacitracin 1 92 Mean Difference (IV, Random, 95% CI) -2.0 [-3.67, -0.33]
63Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2.5 Alcohol vs beniktol 1 76 Mean Difference (IV, Random, 95% CI) -2.33 [-3.77, -0.89]
Comparison 4. Antiseptic vs antiseptic. Studies conducted in hospital settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 Sepsis 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Chlorhexidine vs salicylic
powder
1 213 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.07, 17.50]
2 Omphalitis 5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Triple dye vs alcohol 3 1560 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.14, 1.63]
2.2 Triple dye vs povidone-
iodine
1 183 Risk Ratio (M-H, Random, 95% CI) 0.15 [0.07, 0.32]
2.3 Triple dye vs salicylic sugar
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 4.29 [0.21, 88.65]
2.4 Triple dye vs katoxin 1 403 Risk Ratio (M-H, Random, 95% CI) 2.13 [0.19, 23.34]
2.5 Triple dye vs fuchsine 1 382 Risk Ratio (M-H, Random, 95% CI) 1.92 [0.18, 20.97]
2.6 Alcohol vs povidone-
iodine
1 182 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.62, 1.16]
2.7 Alcohol vs salicylic powder 1 345 Risk Ratio (M-H, Random, 95% CI) 4.69 [0.23, 97.03]
2.8 Alcohol vs green clay
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 2.07 [0.19, 22.60]
2.9 Alcohol vs katoxin 1 365 Risk Ratio (M-H, Random, 95% CI) 2.10 [0.19, 22.97]
2.10 Alcohol vs fuchsine 1 365 Risk Ratio (M-H, Random, 95% CI) 2.10 [0.19, 22.97]
2.11 Alcohol vs chlorhexidine 1 100 Risk Ratio (M-H, Random, 95% CI) 2.77 [0.12, 66.49]
2.12 Chlorhexidine vs
hydrophobic gauze
1 2441 Risk Ratio (M-H, Random, 95% CI) 1.36 [0.55, 3.36]
3 Bacterial colonization:
Staphylococcus aureus9 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Triple dye vs alcohol 2 487 Risk Ratio (M-H, Random, 95% CI) 0.45 [0.25, 0.80]
3.2 Triple dye vs silver
sulphadiazene
3 384 Risk Ratio (M-H, Random, 95% CI) 0.36 [0.25, 0.50]
3.3 Triple dye vs salicylic sugar
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 0.43 [0.16, 1.12]
3.4 Triple dye vs povidone-
iodine
1 62 Risk Ratio (M-H, Random, 95% CI) 0.65 [0.03, 12.87]
3.5 Triple dye vs green clay
powder
1 379 Risk Ratio (M-H, Random, 95% CI) 0.27 [0.11, 0.65]
3.6 Triple dye vs katoxin
powder
1 382 Risk Ratio (M-H, Random, 95% CI) 0.26 [0.11, 0.63]
3.7 Triple dye vs fuchsine 1 382 Risk Ratio (M-H, Random, 95% CI) 1.92 [0.18, 20.97]
3.8 Alcohol vs green clay
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 0.59 [0.30, 1.16]
3.9 Alcohol vs katoxin 1 386 Risk Ratio (M-H, Random, 95% CI) 0.21 [0.12, 0.37]
3.10 Alcohol vs fuchsine 1 365 Risk Ratio (M-H, Random, 95% CI) 0.57 [0.29, 1.12]
3.11 Alcohol vs salicylic
powder
1 345 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.43, 2.03]
64Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3.12 Alcohol vs povidine-
iodine
1 182 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.62, 1.16]
3.13 Chlorhexidine vs
hydrophobic gauze
1 2441 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.70, 1.15]
3.14 Chlorhexidine vs alcohol 2 165 Risk Ratio (M-H, Random, 95% CI) 0.41 [0.24, 0.71]
3.15 Chlorhexidine vs
mercurochrome
1 65 Risk Ratio (M-H, Random, 95% CI) 0.11 [0.01, 2.04]
4 Bacterial colonization:
Streptococcus
3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
4.1 Triple dye vs alcohol 1 373 Risk Ratio (M-H, Random, 95% CI) 0.46 [0.04, 4.99]
4.2 Triple dye vs silver
sulphadiazene
2 326 Risk Ratio (M-H, Random, 95% CI) 1.26 [0.71, 2.25]
4.3 Triple dye vs salicylic sugar
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 0.12 [0.02, 0.98]
4.4 Triple dye vs green clay
powder
1 379 Risk Ratio (M-H, Random, 95% CI) 0.02 [0.00, 0.14]
4.5 Triple dye vs katoxin
powder
1 403 Risk Ratio (M-H, Random, 95% CI) 0.02 [0.00, 0.11]
4.6 Triple dye vs fuchsine 1 382 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.04, 5.24]
4.7 Alcohol vs green clay
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 0.04 [0.01, 0.17]
4.8 Alcohol vs katoxin 1 386 Risk Ratio (M-H, Random, 95% CI) 0.03 [0.01, 0.14]
4.9 Alcohol vs fuchsine 1 365 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.15, 7.38]
4.10 Alcohol vs salicylic
powder
1 345 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.43, 2.03]
5 Bacterial colonization: E. coli 4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
5.1 Triple dye vs alcohol 1 373 Risk Ratio (M-H, Random, 95% CI) 3.44 [2.10, 5.64]
5.2 Triple dye vs silver
sulphadiazene
1 200 Risk Ratio (M-H, Random, 95% CI) 1.36 [1.02, 1.81]
5.3 Triple dye vs salicylic sugar
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 3.92 [2.28, 6.72]
5.4 Triple dye vs green clay
powder
1 379 Risk Ratio (M-H, Random, 95% CI) 1.83 [1.27, 2.65]
5.5 Triple dye vs katoxin
powder
1 403 Risk Ratio (M-H, Random, 95% CI) 2.07 [1.43, 3.00]
5.6 Triple dye vs fuchsine 1 382 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.84, 1.54]
5.7 Alcohol vs green clay
powder
1 362 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.31, 0.92]
5.8 Alcohol vs salicylic powder 1 345 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.58, 2.24]
5.9 Alcohol vs katoxin 1 386 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.35, 1.04]
5.10 Alcohol vs fuchsine 1 365 Risk Ratio (M-H, Random, 95% CI) 0.33 [0.20, 0.55]
5.11 Chlorhexidine vs
hydrophobic gauze
1 2441 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.31, 2.00]
5.12 Chlorhexidine vs
mercurochrome
1 65 Risk Ratio (M-H, Random, 95% CI) 0.21 [0.01, 4.13]
6 Time to cord separation (days) 10 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 Triple dye vs alcohol 2 444 Mean Difference (IV, Random, 95% CI) 0.43 [-8.49, 9.35]
6.2 Triple dye vs silver
sulphadiazene
2 117 Mean Difference (IV, Random, 95% CI) 0.15 [-6.20, 6.51]
6.3 Triple dye vs salicylic sugar
powder
1 362 Mean Difference (IV, Random, 95% CI) 6.0 [5.01, 6.99]
65Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
6.4 Triple dye vs povidone-
iodine
1 58 Mean Difference (IV, Random, 95% CI) 7.60 [3.96, 11.24]
6.5 Triple dye vs green clay
powder
1 379 Mean Difference (IV, Random, 95% CI) 4.90 [3.92, 5.88]
6.6 Triple dye vs katoxin
powder
1 403 Mean Difference (IV, Random, 95% CI) 3.30 [2.28, 4.32]
6.7 Triple dye vs fuchsine 1 382 Mean Difference (IV, Random, 95% CI) 1.30 [0.17, 2.43]
6.8 Alcohol vs green clay
powder
1 362 Mean Difference (IV, Random, 95% CI) 10.2 [9.05, 11.35]
6.9 Alcohol vs katoxin 1 386 Mean Difference (IV, Random, 95% CI) 8.60 [7.42, 9.78]
6.10 Alcohol vs salicylic
powder
1 345 Mean Difference (IV, Random, 95% CI) 11.30 [10.14, 12.46]
6.11 Alcohol vs fuchsine 1 365 Mean Difference (IV, Random, 95% CI) 6.60 [5.32, 7.88]
6.12 Alcohol vs silver
sulphadiazine
1 155 Mean Difference (IV, Random, 95% CI) -4.04 [-4.96, -3.12]
6.13 Chlorhexidine vs salicylic
powder
1 213 Mean Difference (IV, Random, 95% CI) 3.0 [2.46, 3.54]
6.14 Chlorhexidine vs
hydrophobic gauze
1 2441 Mean Difference (IV, Random, 95% CI) -0.40 [-0.57, -0.23]
6.15 Chlorhexidine vs
mercurochrome
1 152 Mean Difference (IV, Random, 95% CI) 6.40 [5.25, 7.55]
6.16 Povidine-iodine vs silver
sulphadiazene
1 86 Mean Difference (IV, Random, 95% CI) -4.0 [-5.53, -2.47]
6.17 Triple dye plus alcohol vs
triple dye alone
1 90 Mean Difference (IV, Random, 95% CI) 1.00 [-0.45, 2.45]
Comparison 5. Single vs multiple application. Studies conducted in community settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality 1 (Random, 95% CI) 0.85 [0.70, 1.03]
1.1 Chlorhexidine 1 (Random, 95% CI) 0.85 [0.70, 1.03]
2 Omphalitis: Algorithem 1 1 (Fixed, 95% CI) 1.14 [0.97, 1.34]
2.1 Chlorhexidine 1 (Fixed, 95% CI) 1.14 [0.97, 1.34]
3 Omphalitis: Algorithem 2 1 (Fixed, 95% CI) 1.53 [1.22, 1.92]
3.1 Chlorhexidine 1 (Fixed, 95% CI) 1.53 [1.22, 1.92]
4 Omphalitis: Algorithem 3 1 (Fixed, 95% CI) 2.12 [1.10, 4.11]
4.1 Chlorhexidine 1 (Fixed, 95% CI) 2.12 [1.10, 4.11]
5 Bacterial colonization:
Staphylococcus aureus1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
5.1 Chlorhexidine 1 3449 Risk Ratio (M-H, Random, 95% CI) 3.63 [2.74, 4.82]
6 Bacterial colonization:
Streptococcus
1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
6.1 Chlorhexidine 1 3449 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.67, 1.53]
7 Bacterial colonization: E. coli 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
7.1 Chlorhexidine 1 3449 Risk Ratio (M-H, Random, 95% CI) 1.17 [1.03, 1.32]
66Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 6. Single vs multiple application. Studies conducted in hospital settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 Cord separation time (days) 4 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Triple dye 3 408 Mean Difference (IV, Random, 95% CI) -4.24 [-4.41, -4.07]
1.2 Zinc powder 1 800 Mean Difference (IV, Random, 95% CI) -0.02 [-0.31, 0.27]
Comparison 7. Washing cord vs dry cord care. Studies conducted in community settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality 1 Risk Ratio (Fixed, 95% CI) 1.0 [0.76, 1.32]
2 Omphalitis: Algorithem 1 1 (Fixed, 95% CI) 1.03 [0.87, 1.22]
3 Omphalitis: Algorithem 2 1 (Fixed, 95% CI) 0.88 [0.69, 1.12]
4 Omphalitis: Algorithem 3 1 (Fixed, 95% CI) 1.01 [0.58, 1.76]
5 Cord separation time (days) 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
Comparison 8. Washing cord vs dry cord care. Studies conducted in hospital settings
Outcome or subgroup titleNo. of
studies
No. of
participants Statistical method Effect size
1 Bacterial colonization:
Staphylococcus aureus1 181 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.65, 1.34]
67Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
F E E D B A C K
Aydin, 27 July 2013
Summary
Chlorhexidine gluconate is a widely used topical antiseptic that is recommended by the Center for Disease Control and Prevention for
skin cleansing before central venous catheter insertion in adults and children. But, because of limited safety data, infection prevention
guidelines do not recommend its use in babies who are less than two months old. There are many reports on the potential toxicity
of chlorhexidine gluconate, for example genotoxic and cytotoxic effects (1). Chlorhexidine gluconate contact may cause corneal
damage, ototoxicity, and neurotoxicity (2). In one study chlorhexidine gluconate was detected in the blood of preterm infants receiving
chlorhexidine gluconate skin antisepsis for peripherally central catheter insertion (3). Further investigation is required to determine the
safety of this use for newborn infants, especially preterm infants.
References
1. Arabaci T, et al. Assessment of cytogenetic and cytotoxic effects of chlorhexidine digluconate on cultured human lymphocytes. Acta
Odontol Scand 2013 71: 1255-60.
2. Zinn J, Jenkins JB,et al. Intraoperative patient skin prep agents: is there a difference. AORN J 2012 92: 662-74.
3. Chapman AK, et al. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion
in preterm neonates. J Perinatol 2013 33):768-71. doi: 10.1038/jp.2013.61. Epub 2013 May 23.
Comment submitted by Mustafa Aydin, July 2013
W H A T ’ S N E W
Last assessed as up-to-date: 25 March 2013.
Date Event Description
27 July 2013 Feedback has been incorporated Feedback 1 received from Mustafa Aydin.
C O N T R I B U T I O N S O F A U T H O R S
Aamer Imdad contributed to the background. Aamer Imdad and Jacinto Blas V Mantaring were primarily responsible for the methods.
Jacinto Blas V Mantaring carried out the additional searches listed in the methods section. Aamer Imdad, Jacinto Blas V Mantaring,
Resti Ma M Bautista, Ma Esterlita V Uy and Kathlynne Anne Abat-Senen reviewed citations for inclusion, extracted data and formulated
the ’Characteristics of included study’ table along with ’Risk of bias’ table. Aamer Imdad, Jacinto Blas V Mantaring, Resti Ma M
Bautista, Ma Esterlita V Uy and Kathlynne Anne Abat-Senen entered outcome data into RevMan, analyzed the data and wrote the
results. Jacinto Blas V Mantaring, Resti Ma M Bautista, Ma Esterlita V Uy and Kathlynne Anne Abat-Senen drafted the discussion
text, which Aamer Imdad and Zulfiqar Ahmed Bhutta subsequently revised. Zulfiqar Ahmed Bhutta provided supervision and is the
guarantor for the review.
68Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D E C L A R A T I O N S O F I N T E R E S T
Aamer Imdad and Zulfiqar Ahmed Bhutta were authors for study Soofi 2012. Data for Soofi 2012 were not extracted by these two
authors.
S O U R C E S O F S U P P O R T
Internal sources
• Effective Health Care Research Programme Consortium, Philippines.
External sources
• SEA-ORCHID Project (South-East Asia - Optimising Reproductive and Child Health Outcomes in Developing Countries),
Australia.
D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E W
1. It was decided post-hoc to include studies on all antiseptics rather than just alcohol. This was to include all possible evidence on
umbilical cord care.
2. Comparison of dry cord care with other antiseptics was not performed as there was too much clinical heterogeneity in the
comparison group.
3. It was decided not to pool community and hospital-based studies together because of significant clinical heterogeneity of
population of patients in hospitals and community settings.
4. Subgroup analyses based on gestational age and that of geographical regions were not performed as the number of studies were
not sufficient.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Umbilical Cord [microbiology]; Anti-Infective Agents, Local [∗administration & dosage]; Chlorhexidine [administration & dosage];
Infant, Newborn; Inflammation [mortality; prevention & control]; Randomized Controlled Trials as Topic; Sepsis [mortality;∗prevention & control]
MeSH check words
Humans
69Umbilical cord antiseptics for preventing sepsis and death among newborns (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.